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A dual plasmid system for the incorporation of unnatural amino acids into plant
pathogen, Pseudomonas syringae pv. tomato DC3000, has been designed. This invention is
expected to allow (a) mutations of proteins synthesized by the bacterium, P. syringae pv. tomato
DC3000, that can capture molecular targets, especially for such modified proteins secreted by the
phytopathogen into the host plant cells of A. thaliana and S. lycopersicum, (b) expression of
biological probes in the bacterial species to monitor changes in redox, nutritional, and other small
molecule states over pre-, post- and in situ disease stages, and (c) secretion of such biological
probes into an infection host organism to monitor intracellular changes of redox, nutritional, and
small molecule states in infected host. This plasmid system will allow proteins to feature
unnatural amino acids in substitution for selected original residues by site-specific alteration of
the protein sequence to the TAG stop codon for recognition exogenous and orthogonal TAGsuppressing tRNA that has been charged with the unnatural amino acid by its cognate tRNA
synthetase (RS). Because the suppressor tRNA and its counterpart synthetase are designed to
only interact with each other, proteins expressed by the bacterial species containing this
orthogonal tRNA/RS pair will enable in vivo production of proteins featuring specialized diseasebased monitoring capabilities. In addition, this plasmid system is expected to be compatible not
only with other pathovars of the P. syringae genus, but also other phytopathogens and soil

bacteria, thereby significantly enhancing the researcher’s ability to understand the role and
response of these microorganisms within their environment.
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Chapter 1 – Introduction and Specific Aims
1.1 General Introduction
Understanding host-pathogen interactions at a molecular level requires ability to identify
which proteins or small molecules are involved in the communication within and between the two
species. Within the host, for instance, signal pathways for normal growth will become altered
once a stress – whether physical, biological, or chemical – has affected the organism. The
response to stress must allow the host species to maintain its normal processes while altering the
local or systemic regions to remedy and repair the self. An entity that directs all of its resources
to stress response and does not maintain normal survival processes will likely suffer and die.
Likewise, the pathogen species must keep its own normal processes functioning while it attempts
invasion of the host and with the host’s response for immunity, the pathogen also becomes
stressed. Indeed, disease events could be seen as an aggressive form of communication where
both entities share a region of immediate interaction, or front line, behind which both species
must organize their secondary preparations and, as the altercation continues, sustain their own
bodies in the event that the battle should end. Immediately, the host or pathogen must begin
repair and subsequent growth, allowing for reproduction and, if necessary, further defense (or
offense) against additional forces. It is not surprising, then, that approaching the disease event
with the perspective of warfare should yield tactics (i.e. espionage) for understanding the
behavior of the players involved and, especially, their respective mechanisms for battle.
It has been shown (Hueck, 1998; Ronald, 2010) that in bacterial diseases of animals or
plants, all classes of biological molecules (e.g. DNA and RNA, proteins, lipid membranes,
polysaccharides, and various signaling molecules) are involved in this hostile tête–à–tête.
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Therefore, the need to understand the chromosomal, transcript, and protein-based responses are
important for recognizing the mechanisms of disease, especially, interactive partners in signaling.
Many pathogens that infect animal or plant hosts are able to manipulate their host’s
cellular activity and structure by secretion of proteins and small molecules into the host cell
bodies. The plant pathogen, Pseudomonas syringae, secretes proteins through a Type III
secretion system – a needle-like apparatus constructed outside the bacteria that creates a portal
into the host cell (Figure 1). This system allows a direct extracellular tunnel between the
bacterial cytosol and the host cytosol such than any secreted proteins, called effector proteins, can
be transported quickly into the host cell body and exert effects to modify the invaded species.
Effector proteins secreted by this system features a secretion-specific terminus peptide sequence
to help the bacterial body properly transport and export the protein into the extracellular
apparatus. It is noted that in virulent bacterial species there are different types of secretion
systems, classified as Type I, II, III, IV, V, a Type VI system (which secretes into both bacterial
and eukaryotic cells) and even a Gram-positive Type VII system (Tseng, 2009; Russell, 2014).
These secretion methods are different than the more common mechanisms in both pathogenic and
non-pathogenic species, such as the Sec-dependent (Pugsley, 1993) and Twin-arginine
translocation system (Bronstein, 2005). Most systems feature an export apparatus for proteins or
small molecules to promote survival of the bacterial pathogen in its new host environment. The
Type IV system, for instance, allows the Agrobacterium tumefaciens to export its Ti (tumorinducing) plasmid into the stalk of the host-plant body, allowing for DNA-based alteration of the
host (Gelvin, 2003); this method, incidentally, has been exploited to impart resistance in tomato
plants from the tobacco mosaic virus, showing that a pathogen’s tool-set can also be a useful tool
for humans.

The Type III system mechanism can likewise be exploited as a useful tool.
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Figure 1: Illustration showing constructed Type III secretion system extending from bacterial
pathogen into plant host cell wall. Also depicted is a generic effector protein (red circle) passing
from invader into infected organism (adapted from Buttner, 2009).
One particular strain of the P. syringae family is P. syringae pv. tomato DC3000
(DC3000), is capable of infecting both its natural host, the tomato plant, and the model plant
Arabidopsis thaliana. The natural host suffers from bacterial black speck (Hueck, 1998), which
causes lesions on leaves and fruits of the tomato plant and resulting in lower harvest and storage
(Cuppels, 1986), while A. thaliana infection produces chlorosis, wilting, and subsequent death
(Katagiri, 2002). Like many other pathogens, DC3000 constructs an effector secretion apparatus
after infiltrating the host body and exports macromolecules into the host cell cytosol. The
DC3000 Type III secretion system is recorded to secrete at least 40 proteins (Cunnac, 2009),
including several that aide in building the pathway from pathogen to host (e.g. harpin proteins),
and some of which work in concert with host native machinery to shift the host’s awareness and
growth phase. A number of secreted effectors require post-translational modification from host
proteins before being able to cause their intended effects.
Currently, there are many effector proteins with unknown targets and it is therefore
important to identify the host substrates for these proteins. Understanding the target of each
effector will help to uncover the dynamics of the molecular basis of disease as caused by
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DC3000. To aide in understanding this basis, the ability to capture a target in situ will be of
greatest benefit, as some protein targets may not be expressed except during the infection process.
However, it is also useful to pinpoint effector proteins in their post-infection location while still
contained within the host cell as this would also shed light on the disease process. A salient
methodology to allow for both methods of analysis, as well as studying pathogen-specific events
leading to and during infection, involves the incorporation of unnatural amino acids (UAA) into
those effector proteins, thereby allowing them to become tools for researchers to study the
pathogen-host system in finer detail. For example, covalent binding of an effector to its target(s)
through use of a crosslinking amino acid (e.g. phenylalanine derivatives featuring benzophenone
or azido substituents; Figure 2), would produce an extractable complex from the lysate of the
host-pathogen cellular mixture. The effector-target complex can be examined to reveal the
protein (or small molecule) counterpart to the bacterial secreted protein. In addition, other amino
acids with different functionality could be used for study, as has been shown in recent literature
(Wang, 2003; Ryu, 2006; Liu, 2010; Coin, 2011).

Figure 2: Crosslinking phenylalanine derivatives, p-azido-L-phenylalanine (AzF; left) and pbenzoyl-L-phenylalanine (BpF; right).

5

The general methodology for producing proteins with unnatural amino acids was
developed by the group of Peter G. Schultz in the early 1990’s (for review: Liu, 2010). The
process allows for in vivo production of peptides and proteins using uniquely interacting tRNA
and tRNA synthetase (RS) pairs, thereby allowing synthesis of polypeptides featuring unnatural
(or alternative) amino acids inserted at the point of an introduced stop codon. The TAG stop
codon is the most frequently used premature stopping site due to its low frequency in most
chromosomes (Povolotskaya, 2012). The DNA sequence for the protein of study is altered by
site-directed mutagenesis to change, for example, a tyrosine residue’s TAT codon to TAG, and
attempted translation from mRNA transcript for this mutated protein would produce a truncated
(and generally inactive) protein. Selection of the amino acid sequence for modification to a stop
codon is dictated by the residue’s location in the protein’s tertiary structure – to allow for
proximity of a target protein – as well as the residue’s role in native protein folding. Altering a
proline residue to BpF, for instance, would likely reduce chance of proper protein folding even
though the surface position of the residue would be the same for protein-protein contact, as
proline generally provides for a specific kink in the molecule’s folded structure.
After successful codon mutation, a pre-selected TAG-specific exogenous tRNA and its
corresponding RS, are then expressed in the organism that produces the mutant protein’s
nucleotide sequence. Upon recognition of the TAG stop codon by this tRNA, premature
polypeptide termination is not engaged, but instead the RS-specific UAA is charged to the
exogenous tRNA and the polypeptide sequence is translated to the full-length protein (Figure 3).
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Figure 3: Illustration to show the effect of orthogonal tRNA and synthetase pair for in vivo
incorporation of an unnatural amino acid (shown as red circle) into protein during translation.
Left-hand molecular species (black) are the native machinery in the organism, while the righthand species (red) are the exogenous and orthogonal tRNA and corresponding synthetase
(retrieved from Wang, 2005).
1.2 Project Overview and Specific Aims
With UAA-incorporation technology, modified forms of effector proteins can be
synthesized within the pathogen and secreted directly into the host cell. This method of in vivo
capture helps to ensure proper location and targeting of effector proteins. In the event an
effector’s target is not produced at a high concentration except during the disease state, pathogen-
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initiation of infection would promote more available target amount for access and capture. A
two-plasmid system has thus been developed to allow for the incorporation of unnatural amino
acids into the plant pathogen, Pseudomonas syringae pv. tomato DC3000, with the intent of
capturing effector targets in planta.
A pair of plasmids is used to individually control the transcription of the exogenous
tRNA and protein of interest, and, separately, the corresponding synthetase. Both the tRNA and
synthetase must be unable to interact with the native DC3000 protein synthesis machinery and so
two sets of plasmid pairs were selected from Archaea, as these are not expected to interact with
eubacterial machinery (Yanagisawa, 2008; Wang, 2010): Methanosarcina spp. which utilize a
pyrrolysine-tRNA/synthetase to naturally suppress TAG codons, and the anti-codon mutated
tyrosyl-tRNA and mutated synthetase from Methanocaldococcus jannaschii. For both sets of
plasmid pairs, the tRNA and GFP reporter protein are both on the same plasmids, pBBR1MCS3
(Kovach, 1995), and the synthetase is expressed from pML123 (Labes, 1990). Both of these
parent vectors were provided by James Alfano (University of Nebraska-Lincoln).
The pBBR1MCS3 vector (TetR; Figure 4) was chosen for housing a GFPuv reporter
protein and the exogenous tRNA. The reporter protein shows fluorescence when fully folded and
a mutation at position, N149, to TAG stop codon (GAU  TAG) yields premature termination of
the translated peptide sequence and thus would produce no full-length or fluorescing protein.
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Figure 4: Plasmid map for pBBR1MCS3 vector for tRNA, GFPuv constructs. {Kovach, 1995}
The pML123 vector (GenR; Figure 5) from pML10 family is used as the synthetase vector
for which several promoters have been positioned upstream the multiple cloning site (Table II,
Labes, 1990). Vector pML123 (and pML122) possesses neomycin acetyltransferase promoter
and terminator regions to yield strong promotion in soil bacteria, but not E. coli. Therefore,
pML123 was modified to feature tac and T5 promoters and their corresponding ribosome binding
sites in this study, expecting moderate expression in both E. coli and P. syringae DC3000.
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Figure 5: Plasmid map for pML123 vector for synthetase constructs. {Labes, 1990}
1.2.1 Methanosarcina barkeri Pyl-tRNACUA and Methanosarcina mazei Pyl-tRNA Synthetase
Several Methanosarcina spp. utilize an unusual amino acid, pyrrolysine, and possess
unique tRNA and synthetase pairs for incorporation of this amino acid in their biological
framework. The native anticodon arm (CUA) for the pyrrolysyl-tRNA recognizes the codon,
TAG (Srinivasan, 2002).
This thesis study employs the pyrrolysyl-tRNA (Pyl-tRNA) to recognize the TAG stop
codon and a cognate synthetase developed (Yanagisawa, 2008) for incorporation of unnatural
amino acids, including a boc-protected lysine, which can be inserted into proteins of study.
Investigations involved use of the wild-type cognate pyrrolysine-tRNA synthetase (PylRS), a
mutant with higher affinity for boc-lysine (PylRS Y348F), and a mutant evolved to better
recognize natural amino acids (PylRS NAA, or PylRSNAA). Pyl-tRNA/RS pair was the first
studied in P. syringae DC3000, to investigate the tRNA transcription under native DC3000 tRNAmet-3 promoter and terminator regions. This tRNA expression was the first step in successful
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incorporation of UAAs. In addition, this project also utilizes different promoters for the
synthetase plasmid (tac and T5) in attempt to enhance RS expression in P. syringae DC3000.
1.2.2 Methanocaldococcus jannaschii Tyrosyl-tRNACUA and Evolved M. jannaschii Synthetase
A dual plasmid system was also designed to feature M. jannaschii Tyr-tRNACUA and
cognate synthetase, by which the wild-type tyrosyl-tRNA synthetase (TyrRS WT), and two
evolved RS specific for either p-benzoyl-L-phenylalanine (BpF) or p-azido-L-phenylalanine
(AzF) were analyzed separately. Both the BpF and AzF amino acid derivatives of phenylalanine
have been shown to yield successful covalent capture of protein targets (Chin, 2002; Chin, 2002).
Further study involved modifying the M. jannaschii Tyr-tRNA promoter sequences to
alter product transcription. The prokaryotic promoters, lpp, an upstream promoter for the E. coli
outer membrane lipoprotein (Inouye, 1985), and proK, featured in the E. coli prolyl-tRNA codon
(Ryu, 2006) were chosen for this procedure. Our laboratory possessed vectors which contained
the Tyr-tRNA already downstream the lpp or proK promoters, as well as all tRNA/RS pairs.
Although successful expression of the full-length mutant GFPuv N149TAG can be
detected by fluorescence, it is beneficial to confirm reporter protein expression by visualization of
proteins by electrophoretic and Western blot membrane development methods. These methods
were employed for additional confirmation of achieving unnatural amino acid incorporation via
the present invention.
Results and methods for constructing a two plasmid system for successful incorporation
of unnatural amino acids into P. syringae pv. tomato DC3000 are provided in this thesis.
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Chapter 2. Investigation of Promoters for Transcription of Exogenous tRNA and tRNA
Synthetase in Pseudomonas syringae pv. tomato DC3000.
2.1 Identifying a Native P. syringae DC3000 Promoter for Exogenous tRNA
Incorporation of unnatural amino acids into living species requires the addition of an
exogenous tRNA and corresponding synthetase that have a high affinity for the amino acid to be
incorporated but have little or no affinity to natural amino acids. This selectivity is first acquired
by modification of the tRNA and synthetase structures by site-directed mutagenesis and evolution
of these molecular species during growth assays in presence of the unnatural amino acid.
However, fine-tuning the tRNA and synthetase is only useful insofar as the molecules can
be used within the species of study. Effective expression of these components in vivo is required
to install unnatural amino acids into proteins of study and for all these processes there must be
promotion of the tRNA and synthetase transcripts (1) at an effective rate to meet the demands of
the ribosomal machinery synthesizing the nascent peptide chain for any proteins of study, (2) at a
level low enough to not create toxic results from these exogenous molecules, (3) as a stable form
of tRNA or synthetase that can exist long enough within the cell to allow for the first case, above.
Case (2) is especially important if during the selection and evolution process the tRNA or
synthetase still interact with endogenous protein translation machinery. Finally, there must be a
method for observing the efficacy of tRNA and synthetase production and activity, i.e. Northern
blot, protein-based electrophoresis, or reporter protein.
To enable incorporation of unnatural amino acids into P. syringae DC3000 by use of
exogenous tRNA, the host organism must promote transcription of the tRNA for expression
without degradation of the gene product before it is cleaved to maturity. Therefore, this project
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required designing a tRNA gene cassette having 5’ and 3’ regions naturally found in P. syringae
DC3000.
One promoter sequence expected to be effective in P. syringae DC3000 is that for tRNA
genes. Initiator tRNA (Met) promoters are shown to yield high transcript products for pathogenic
bacteria, such as Mycobacterium tuberculosis (Vasanthakrishna, 1997) and such promoters have
been used to express exogenous tRNA in that same species (Wang, 2010). Although, P. syringae
DC3000 is not an animal pathogen, it can be assumed that native initiator tRNA promoter and
terminal regions would be similarly effective for this plant pathogen. Because stable RNA in vivo
require (a) a consensus upstream sequence that is regulated to produce an appropriate supply of
transcript and (b) the downstream poly(A) tail to provide for recognizable precursor-tRNA that
can be processed into the active unit, the expression of an exogenous tRNA within P. syringae
DC3000 should be successful when using the 5’ and 3’ regions from native tRNA genes. In
addition, control studies in E. coli using P. syringae DC3000 5’ and 3’ regions of the initiator
tRNA are expected to yield functional products, although likely at a lower level than for the
native organism.
Using the E. coli gene metY as the proto-type for an initiator tRNA in DC3000,
nucleotide BLAST of the E. coli DH1 methionyl-tRNA, metY (NC_017638.1), against the
DC3000 genome showed a 93% identity with tRNA-met-5 (NC_004578.1). It was expected that
the native 5’ and 3’ flanking regions would be sufficient for transcription and processing of any
exogenous tRNA. However, as is shown in Figure 7, the met-5 initiator tRNA appears
downstream to tRNA-leucyl-4, making possible difficulty ensuring the promoter region could be
easily amplified via PCR without contamination of unwanted DNA. Therefore, the flanking
regions of another methionyl-tRNA, tRNA-met-3, from P. syringae DC3000 was chosen (Jiantao
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Guo, UNL) for amplification and tRNA cassette construction. This process was performed using
PCR was used to amplify the 5’ and 3’ regions of P. syringae DC3000 tRNA-met-3 from genomic
DNA and these regions were used to flank the M. barkeri Pyl-tRNA gene via overlapping PCR.
This tRNA cassette was then inserted into the vector containing the GFPuv reporter protein
sequence.

Figure 6: Nucleotide BLAST showing 93% homology between E. coli DH1 (Subject) and P.
syringae DC3000 (Query); (http://www.ncbi.nlm.nih.gov/)
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Figure 7: Reference location of P. syringae DC3000 tRNA-Met-5 within genetic region as found
within NCBI information site. Image shows leucyl-tRNA upstream in same locus and so tRNAmet-5 was later substituted for tRNA-met-3.

Figure 8: Reference location of P. syringae DC3000 tRNA-Met-3 within the genetic region as
found within NCBI information site.
2.2 Developing tRNA, GFPuv and Synthetase Plasmids for Testing tRNA Promotion
Plasmids containing the GFPuv reporter protein as wild-type or N149TAG mutant were
prepared and, for mutant GFPuv, the Pyl-tRNA gene cassette featuring P. syringae DC3000
tRNA-met-3 promoter region was prepared. The tRNA-met-3 terminator region provided
difficulty in cassette design and so the Pyl-tRNA, upon initial amplification from house vector,
was amplified with a designed poly(A) tail to allow for proper in vivo processing. It was not
observed that strains featuring only the mutant GFPuv N149TAG and any suppressor tRNA give
fluorescence results to suggest DC3000 houses TAG stop codon suppressor machinery. This
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result is not surprising given the low frequency of TAG in the P. syringae DC3000 genome, as
shown in Table 1, below (Nakamura, 2000). Indeed, it was not expected that any TAG
suppression native to DC3000 would cause significant false positive results in studies involving
biological probes or crosslinking amino acids, as strains induced with the necessary UAA at 1.0
mM or greater concentrations should promote higher UAA-incorporated mutant proteins rather
than natural amino acid positioning in the TAG stop codon site.
The following results are organized to reflect the methods in Chapter 4. Plasmid
construct images are shown, followed by initial cell-based fluorescence assays for strains
featuring that construct.
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Table 1: Codon analysis frequency in P. syringae pv. tomato DC3000. Stop codon frequency is
highlighted by red border in upper right-hand corner of table. {Nakamura, 2000 ; retrieved
directly from: http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=223283 (June 6,
2014)}
2.2.1 pBBR1MCS3-GPFuv N149TAG and pBBR1MCS3-GFPuv WT
Reporter protein plasmids were constructed and tested for fluorescence in E. coli
Genehog, E. coli NEB5α, and DC3000, as single transformants or in presence of exogenous
synthetase. Fluorescence data is shown in subsequent sections.

v

v+i

Figure 9: Plated Genehog cells for ligation product from pBBR1MCS (v-only; left) with
GFPuvN149TAG cassette insert (v+i; right). Results are similar for GFPuv WT ligation.
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2.2.2 pBBR1MCS3-GFPuv N149TAG-Mb. Pyl-tRNA (pSR6.067)
Use of pBBR1MCS3-GFPuv N149TAG for construction of pSR6.067 containing the PyltRNA allowed for transformation of Genehog and DC3000 wild-type cells. Cells were inoculated
to liquid culture and grown in their optimal environments, induced, and later analyzed for
fluorescence of cells pellets or culture liquid supernatant.

Figure 10: Genehog cells on LB/Tet10 agar plates for pSR6.067 ligation product. (Abbrev.: v,
vector only control; v+i, vector + Pyl-tRNA insert.)
2.2.3 pML123-tac-PylRS WT
Construction of the synthetase-containing vector involved several steps, including an
intermediate plasmid to create a promoter cassette featuring the tac promoter, as vector, pML123
contains the strongly-promoting neomycin promoter and as the tac promoter is useful in both E.
coli and P. syringae (Labes, 1990), using this latter promoter offered a good positive control
during plasmid development in both strains. Vector was co-transformed into Genehog and
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DC3000 cells along with either pBBR1MCS-GFPuvN149TAG only, or pSR6.067 (Pyl-tRNA,
GFPuvN149TAG). Co-transformed cells were analyzed for fluorescence of cell pellets and liquid
culture suspensions.
Transformation of DC3000 (DC), by electroporation or Genehog cells (G), by heat shock,
with pSR6.067 was successful and subsequent transformation of DC:pSR6.067 with pML123PylRS (electroporation) or G:pSR6.067 chemical competent cells with pML123-PylRS allowed
for inoculation into liquid media and induction of Pyl-tRNA/RS machinery with 0.3 mM IPTG
and 5 mM Boc-lysine.
Fluorescence experiments (Table 2; Graph 1) show fluorescence only for induced
Genehog cells (OD600 0.05) with added boc-lysine (5 mM). Repeated attempts at incubating
induced DC3000 cells at room temperature (RT) or 30 oC did not result in fluorescence.
Nevertheless, it was apparent the Pyl-tRNA gene cassette featuring the DC3000 promoter
region functioned properly, as shown by the high fluorescence in Genehog cells under induction
with Boc-lysine added. With this noted success of the tRNA cassette functionality, efforts turned
to investigate the exogenous synthetase activity in P. syringae DC3000 -- by substituting with
mutant synthetase (PylRS Y348F and PylRSNAA) and altering promoter regions in the pML123
vector from tac to T5.
Strain:Plasmid
DC3000 WT
DC:GFPuv WT non
DC:GFPuv WT ind DC:6.067 non
DC:6.067 ind G:6.067+Ptac.PylRS WT non
G:6.067+Ptac.PylRS WT ind G:6.067+Ptac.PylRS WT ind +

OD600
4.00
13.2
13.5
4.20
4.70
1.40
1.40
1.60

ODfluor
RFU
Dev.
Reported +/0.05 -11.125 37.76029 -11.1
37.8
0.05
2710 84.59314 2710
84.6
0.05 5698.333 16.19671 5700
16.2
0.05
79 84.59314 79.0
84.6
0.05 35.66667 16.19671 35.7
16.2
0.05
700 255.9727
700
256
0.05 379.3333 77.51344
380
77.5
0.05
5417 323.9182 5420
324
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Table 2: Single trial test for fluorescence of GFPuv (WT or N149TAG) in DC3000 or Genehog
cells with all samples incubated for 19 hours and densities normalized to OD600 0.05 for analysis.
For ease of comparison, “Reported RFU +/- RFU” shown in right-hand columns. DC3000 WT,
wild-type strain DC3000; DC3000:pBBR-GFPuv WT non-induced (non) and 0.3 mM IPTG
induced (ind-) DC3000 transformed with pSR6.067 (listed as DC:6.067); G:6.067+Ptac.PylRS
WT, Genehog transformed with pSR6.067 and pML123.tac.PylRS WT feat. non, ind-, and IPTG +
5 mM boc-lysine (ind+).

Graph 1: Counterpart for Table 1, showing relative fluorescence of cells for DC3000 wild-type
(blank), and DC3000, Genehog transformed strains as non-induced (non), IPTG induced (ind-)
and IPTG + 5 mM boc-lysine (ind+). (Abbrev. as DC, DC3000; GFPuv WT, pBBR1MCS3GPFuv WT; 6.067, pSR6.067; G, Genehog; Ptac.PylRS WT, pML123.tac.PylRS WT. Error bars
reflect consistency being multiple measurements for same samples to denote precision of
scanning with SynergyH1 reader).
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Strain:Plasmid
DC3000 WT
DC:6.067:Ptac.PylRS WT non
DC:6.067:Ptac.PylRS WT indDC:6.067:Ptac.PylRS WT ind+

OD600 ODfluor
RFU
4.0
0.05
5.7
0.05
5.8
0.05
4.9
0.05

666
353
448
263

Table 3: Single trial fluorescence of DC3000 with pSR6.067, pML123.tac.PylRS WT in
comparison to DC3000 wild-type (WT) cells. Abbrev. DC, DC3000; 6.067, pSR6.067;
Ptac.PylRS WT, pML123.tac.PylRS WT; non, non-induced; ind-, IPTG induced; ind+, IPTG
induced + boc-lysine. Single scan for suspensions normalized to 0.05 OD600. DC3000 WT
considered as blank; correction not done to show positive RFU values.
2.3.1 Analysis of DC3000:pSR6.067 featuring pML123-tac.PylRS Y348F
PCR amplification of PylRS Y348F from pBK vector resulted in digestible product that
was prepared as for PylRS WT to produce

Sample
Blank
G:6.067:YF non
G:6.067:YF ind
DC:6.067:YF non
DC:6.067:YF ind
DC:6.067 only

ODfluor
N/A

RFU
0.1
0.1
0.1
0.1
0.1

RFU/OD

0
0
37.5
375
1329.5
13295
-10 N/A
-1.5 N/A
40
400

Table 4: Initial test for GFPuv mutants from Genehog (G) or DC3000 (DC) cells containing
pSR6.067 (6.067) and pML123.tac-PylRS Y348F (YF). PBS blank, non-induced (non) and
induced (ind) with IPTG and 5 mM boc-lysine.
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Sample
Blank

12 hrs. PI
ODfluor

RFU

N/A

24 hrs. PI

RFU/OD Reported ODfluor
0 N/A

RFU

0 N/A

RFU/OD Reported
0 N/A

0

DC:6.067
6.067,WT non
6.067, WT ind+

1.1375
1.074
0.8315

682.5
600.0
692.5 644.7858
694 834.6362

600.0
644.8
835

1.1285
0.99
0.9385

2888.5 2559.592
2812.5 2840.909
1530.5 1630.794

2559.6
2800
1630.8

6.067, YF non

1.106

723 653.7071

654

1.093

2715.5 2484.446

2485

6.067, YF ind+

0.758

1442 1902.375

1900.

0.759

1695.5

2234

Sample
Blank

48 hrs. PI

36 hrs. PI
ODfluor
N/A

RFU

RFU/OD Reported ODfluor
0 N/A

2233.86

0

RFU

RFU/OD Reported
0 N/A

0

DC:6.067

0.9555

10231.5 10708.01

10710

0.767

9078.5 11836.38

11800

6.067,WT non
6.067, WT ind+
6.067, YF non

0.866
0.7735
0.9255

6190 7147.806
4332 5600.517
7633 8247.434

7150
5600.
8247.4

0.552
0.6795
0.852

4426.5 8019.022
4839.5 7122.149
7565 8879.108

8020
7122
8880

6.067, YF ind+

0.62

3164.5 5104.032

5100

0.5555

3314.5 5966.697

5966.7

Table 5: RFU/OD values for 48-hour time course of non-induced (non) and induced (IPTG and
boc-lysine; ind+) DC3000 cells containing pSR6.067 (6.067) with pML123.tac-PylRS (WT or
Y348F). Abbrev: P.I., hours post induction; WT, pML123.tac.PylRS WT; YF, pML123.tac.PylRS
Y348F; DC:6.067 (DC3000:pSR6.067 only).
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Graph 2: RFU/OD values for samples shown in Table 5. No strains featured higher fluorescence
than Pyl-tRNA, GFPuv n149TAG, suggesting the synthetase promoter was at fault Abbrev. 6.067,
pSR6.067; WT, pML123.tac.PylRS WT; YF, pML123.tac.PylRS Y348F. .
A useful method for detecting successful of the dual plasmid system requires
reproducible fluorescence increase over non-induced (non) cells for those samples induced with
both IPTG and the unnatural amino acid (ind+). These “ind +” cell pellets should also always
show higher fluorescence than IPTG-only induced (ind –) pellets. There was no attempt at
analyzing fluorescent of pellets for DC3000:pBBR1MCS3 strain; the wild-type DC3000 and
transformed strains featuring reporter proteins were suitable controls for this project.
Cell-based fluorescence assay for DC3000:6.067:PylRS (WT, Y348F) showed the
pyrrolysine tRNA/RS system worked well in E. coli, but it was considered to change the
synthetase promoter from tac to T5 to better understand lack of success in DC3000. After
changing promoters, values of fluorescence dependent on adding boc-lysine to the culture
significantly increased over non-induced cultures. However, analysis of samples induced with
IPTG only also produced significantly high fluorescence. Because of this, it appeared that either
the Pyl-tRNA or the PylRS was interacting with DC3000 native translational machinery.
After the wild-type PylRS did not show the expected high fluorescence in DC3000, it
was decided to construct the synthetase vector for the DC3000 system using the Tyr348Phe
pyrrolysine synthetase mutant (PylRS Y348F), with intent that the mutant would provide brighter
fluorescence for the GFPuv reporter in induced strains due to higher affinity for the Boc-lysine
amino acid (Yanagisawa, 2008).
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Initial test of GFPuv mutants from Genehog and DC3000 featuring pSR6.067 and
pML123.tac.PyRS Y368F are shown in Table 2. Incidentally, Genehog-expressed GFPuv N149boc-lysine fluorescence was not as intense as expected and a second test was run for induced
DC3000 cells harboring either the PylRS Y368F mutant or a second pML123.tac.PylRS WT
(PylRS #2) plasmid, but results for DC3000 were similar (data not shown).
2.3.2 pML123-tac-PylRS NAA Mutant
The Pyl-tRNA/RS system within E. coli Genehog cells gave expected increased
fluorescence for cultures induced and charged with Boc-lysine, but this trend was not observed in
P. syringae DC3000. Considerations for this inconsistency included (a) a mutation in tac, RBS,
or PylRS DNA sequence in the pML123 plasmid, (b) inability for DC3000 to take up/use Boclysine, or (c) poor efficiency of tac promoter for synthetase production in DC3000.
To examine the first possibility, sequencing of the pML123-PylRS vector with primers to
recognize tac promoter site. Results showed no mutation in the promoter, RBS sites, or the
upstream sequence for PylRS.
To examine if DC3000 had trouble importing or utilizing Boc-lysine, we attempted to use
a library of PylRS variants prepared in our lab (Tong Ju, University of Nebraska-Lincoln) to
select for a synthetase that could recognize natural amino acids (NAA). Use of a PylRSNAA
would still allow for interaction with the Pyl-tRNA but charge the tRNA with natural amino acids
to produce a full-length and fluorescing GFPuv N149-NAA protein.
This selection process required the use of E. coli cells containing the pREP-PylT plasmid
(Neumann, 2008) featuring a T7 RNA polymerase and a chloramphenicol acetyltransferase
(CAT) that both possess TAG stop codons within the peptide sequence -- two stop codons in the
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polymerase, one in the resistance protein -- as well as the suppressor Mb. Pyl-tRNACUA for PylRS
interaction. Properly suppressed TAG codons allow for full-length synthesis of the polymerase
which will recognize the plasmid-based T7 promoter region preceding the plasmid’s wild-type
GFPuv reporter protein. Expression of full-length CAT from the plasmid yields chloramphenicol
resistance with increasing TAG suppression due to effective synthetase charging of natural amino
acids to the suppressor tRNA.
The following results feature plated cells related to the evolution of PylRS Y348F
synthetase with increased selectivity for natural amino acids (PylRSNAA).

Figure 11: BL-5 library plates for 105 and 107 cells prepared from glycerol stock. Two colonies
from the 107 plate were chosen for purify PylRSNAA, a synthetase to recognize natural amino
acids.
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Figure 12a: Plated E. coli pREP-PylT cells (see below) for transformants prepared from plasmids
purified from initial BL-5 plating.

Figure 12b: Transformed Genehog cells from ligation of digested pJF118EH-mod1 (v-only; left)
and digested PylRSNAA insert (v+i; right).
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Figure 13: DNA gel for Genehog plated cells from ligation of digested pML123 (v-only; left) and
PylRSNAA insert (v+i; right). Ligation efficiency for v:v+i was 6:15 colony forming units.
As shown in Figure 11, a single-round selection yielded viable colonies in presence of
chloramphenicol (50 µg/mL), but recombination, transformation, and growth under IPTG
produced no significant GFPuvN149-NAA fluorescence in DC3000 cells (data not shown).
Therefore, it was decided that the synthetase promoter should be switched from tac to the same
T5 promoter cassette as used with the GFPuv reporter proteins.
As a final note on use of Boc-lysine in DC3000, there has been little research into the
effective uptake of unnatural amino acids into P. syringae and different bacterial species are
likely to have subtle differences in their specific amino acid import/transport machinery. A
survey of the KEGG database shows such differences between DC3000 (left) and E. coli DH10B
(right) strains as shown in Figure 14. The ArgT protein (red border; left column; white box) may
be tantamount for uptake of Boc-lysine in DC3000, for example, given its categorized role in
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transport of lysine, arginine, and ornithine – all polyamine amino acids. However, other
transporter proteins (e.g. HisM) may be suspect to recognition of Boc-lysine, in this case.
A supplemental study of any unnatural amino acid uptake in DC3000, would involve
addition of the amino acid to mid-log phase DC3000 cells in culture media followed by collecting
of supernatant over given time-points for analysis by LC-MS/MS. This method could be easily
complemented by introduction of exogenous or overexpressed native transporter proteins into the
host, followed by growth under similar conditions for analysis. To note, however, in the event an
organism of study does not need or cannot use the amino acid, there is always a chance of
excretion of the molecule back into the supernatant. In the case of Boc-lysine, if effective uptake
was accompanied by ineffective use, the amino acid could be expected to be released back into
the environment in total or degraded for recycling of useable functional groups and waste release.
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Figure 14: Comparison of phosphate and amino acid transporters between P. syringae pv tomato
DC3000 (left) and E. coli DH10B (right). Blocks highlighted in green are known pathway nodes
found in that organism. For link to the P. syringae pv. tomato DC3000 KEGG site:
{http://www.genome.jp/kegg-bin/show_pathway?pst02010}
2.4 pBBR1MCS3.T5-PylRS WT, pML123.T5-PylRS WT, and pML123.T5-PylRS Y348F
To enhance expression of the synthetase, PylRS (WT or Y34F), an alternative promoter
was selected. It was seen that the GFPuv WT was well expressed in both E. coli and DC3000
cells, so it was decided to use the T5 promoter and ribosome binding site (RBS) for increasing
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synthetase production. As the T5.RBS.GFPuv WT (or N149TAG) cassette was initially cut from
a pLei-based vector, substitution of the reporter protein for either synthetase allowed for direct
insertion of T5.RBS.PylRS (WT or Y348F) from pLei vector into plasmids pML123 and also
pBBR1MCS3. Vector pBBR1MCS3 had shown successful expression (as per fluorescence) of
GFPuv WT from DC3000 so this construct was created for possible troubleshooting of synthetase
expression. That is, if there had been a problem with the new pML123.T5 constructs, the
pBBR1MCS3.T5 series would have served as an additional experimental control.
Shown below in Figures 15, 16 are the plates for E. coli cells transformed with ligation
products at first and second stages of experimental design. Fluorescence results are shown in
Table 6.

Figure 15: Plated Genehog cells for ligation of pET28a (v-only; left) with PylRS WT insert (v +
i; right). Plates for PylRS Y348F were similar; vector sample used was same for both.
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Figure 16: Plated Genehog cells for ligation of pML123 (v-only; left) with PylRS Y348F insert (v
+ i; right). Plates for PylRS WT ligation and transformation utilized same vector sample.

Sample
Blank
KB-T/Tet10
DC WT
6.067:PylRS WT non
6.067:PylRS WT ind6.067:PylRS WT ind+
6.067:PylRS YF non
6.067:PylRS YF ind6.067:PylRS YF ind+

20 hrs. 30 oC, 16 hrs. 4 oC
43 hrs. 30 oC, 16 hrs. 4 oC
RFU
ODfluor
RFU/OD Reported RFU
ODfluor
RFU/OD Reported
0 N/A
N/A
0
0 N/A
0
0
670. N/A
N/A
670.
670. N/A
N/A
670.
1218.75
0.569 2141.916
2140 N/D
N/A
N/D
N/A
1092.50
0.246 4441.057
4440 1773.25
0.297 5970.539
5970
1159.75
0.174 6665.23
6670 4251.75
0.327 13002.29
13000
829.50
0.332 2498.494
2500 4292.75
0.506 8483.696
8480
1041.00
0.069 15086.96
15100 1460.75
0.05
29215
29200
1486.25
0.119 12489.5
12500
906.50
0.039 23243.59
23200
5472.00
0.298 18362.42
18400 2872.00
0.236 12169.49
12200

Table 6: Comparison of DC3000 cells featuring pSR6.067 (6.067) in presence of either
pML.T5.RBS.PylRS WT (PylRS WT) or pML.T5.RBS.PylRS Y348F (PylRS YF). 20-hour and
43-hour time-points were grown post-induction (0.5 mM IPTG; 5 mM boc-lysine) at 30 oC, 250
rpm and then set into 4 oC for 16 hours. Results of induction with amino acid (ind+) against
induction without amino acid (ind-) showed that over 43-hour period, fluorescence of (ind+) was
lower than that for (ind-). These unexpected results suggest the host strain translation machinery
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may be working with plasmid-based machinery to incorporate natural amino acids into TAG
location of GFPuv N149 reporter protein.
Substitution of the synthetase promoter to the T5 promoter cassette gave increased
fluorescence of the GFPuv reporter protein, but it was realized that a significant increase over
non-induced cultures was apparent (Table 6) without the addition of boc-lysine unnatural amino
acid. These results are not the expected non < ind- < ind+ RFU/OD for transformed P. syringae
DC3000 cultures and, therefore, it was decided that this Pyl-tRNA/RS system would not be
suitable for selectively producing mutant proteins in future experiments. There was no further
attempt to understanding the interactions of exogenous tRNA or synthetase. An alternative
tRNA/RS pair, from Methanocaldococcus jannaschii, was next studied.
For further analysis, however, it was decided to attempt purification of any full-length
GFPuvN149 mutants that may be produced within DC3000 cells under induction alongside Boclysine. Purifications and electrophoretic analyses were performed in concert with P. syringae
DC3000 cultures featuring the M. jannaschii tRNA/RS dual plasmid system; results are therefore
shown in Chapter 3.
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Chapter 3: Construction and Use of Dual Plasmid System Featuring M. jannaschii TyrosyltRNACUA and pML123.T5. Mj. BpFRS (pSR8.010, pSR8.017)
A different tRNA/RS pair was introduced into P. syringae pv. tomato DC3000 from the
Archaea, Methanocaldococcus jannaschii. The tRNA anticodon arm has been modified to
recognize the TAG stop codon; the corresponding synthetase for this Tyr-tRNACUA has been
evolved in separate experiments to select for specific unnatural amino acids. Different synthetase
proteins, including the wild-type TyrRS and the evolved species, BpFRS and AzFRS that specific
for the crosslinking amino acids, BpF and AzF, resp., were studied in presence of the tRNA to
effect full-length translation of the GFPuv reporter protein featuring UAA at position N149TAG.
The full-length GFPuvN149-UAA mutant produces fluorescence when properly folded and also
contains a C-terminal 6xHis tag to allow for purification by nickel affinity column.
3.1 Construction of Vector, pSR8.010, Containing M. jannaschii tRNA and GFPuvN149TAG
The vector containing the GFPuvN149TAG reporter protein, pBBR1MCS3-GFPuv
N149TAG, was modified to include the M. jannaschii Tyr-tRNACUA gene cassette featuring the
P. syringae DC3000 tRNA-met-3 promoter region and the poly(A) tail as in Chapter 2. Analyses
of fluorescence in DC3000:pSR8.010 (8.010) as non-induced or IPTG-induced against wild-type
DC3000 culture were performed against DC3000 wild-type cells at 2-days (Table 7), and 5 days
(Table 8) against DC:6.067 (Pyl-tRNA). In this experiment IPTG induction serves only to give
expression of the GFPuvN149TAG truncated protein. In all cases, there was a level of
background fluorescence for the induced cells. As shown in Table 9, the fluorescence for
DC:8.010 cells (1460 RFU/OD) was higher than for DC:6.067 (513 RFU/OD) under IPTG
induction, suggesting that either the M. jannaschii tRNA was more stable, more highly expressed,
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or better at supplying natural amino acids to the TAG codon site than the M. barkeri tRNA.
Nevertheless, because the GFPuvN149-based fluorescence was generally lower under IPTGinduction (Table 7), and fluorescence measurements for DC3000 cells featuring only the
GFPuvN149TAG construct (Table 9; GFP non, ind) were also higher than wild-type DC3000
cells, it was decided to pursue studies involving vector pSR8.010 in presence of the synthetase
proteins.
Sample
Blank
DC WT
DC:pSR8.010 non
DC:pSR8.010 ind-

RFU
Dev.
RFU/OD Dev.
Reported
Dev.
-0.052593 0.152029 ---0.05
0.15
--478.2639 37.97862
478
38
--2045.848 453.1645
2050
453
--1839.58 437.5054
1840
438

Table 7: Average of three trials for cell fluorescence of DC3000:pSR8.010, featuring the M.
jannaschii Tyr-tRNACUA, GFPuv N149TAG. Cells were incubated 44-48 hours P.I. with 0.5 mM
IPTG working concentration (ind-) or no IPTG (non), followed by 20 hours incubation at 4 oC.
Wild-type DC3000 is shown as reference; OD600 values used for calculating RFU/OD were
between 0.1 and 1.2, as measured by 10x dilution of cell suspension prior to dilution for assay.
DC3000 pSR8.010 120/18 Samples (120 hrs 30 oC, 18 hrs 4 oC)
OD (final) RFU
Dev.
RFU/OD Reported
PBS
N/A
0.333333
53.850 N/A
0.333
WT
1.10
1019
13.697 926.3636
926
8.010 non
1.00
2870.5
37.217
2870.5
2870
8.010 ind1.10
2556
37.202 2323.636
2320

Table 8: Single trial fluorescence test of 120-hour P.I. DC3000:pSR8.010 (8.010) after induction
of mid-log cultures with 0.5 mM IPTG (ind-), incubation at 30 oC, 250 rpm, followed by 18 hours
at 4 oC. OD600 values were obtained at 10x dilution of culture sample and back-calculated for
RFU/OD results. DC3000 wild-type (WT) is shown for comparison.
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Sample

OD600

RFU

Dev.

Blank
N/A
0
WT
7.10 5615.333
GFP non
11.50
11144
GFP ind

RFU/OD Reported

12.910 N/A
36.501 790.892
67.735 969.0435

0
791
969

12.60

14684

199.610 1165.397

1170

8.010 non

5.30

6241

75.974 1177.547

1180

8.010 ind

7.20 10516.33

141.924 1460.602

1460

6.067 non

24.40 23759.33

299.604 973.7432

974

6.067 ind

26.00 13344.67

190.768 513.2564

513

Table 9: Single trial fluorescence test for DC3000 containing pBBR1MCS3-GFPuv N149TAG
only (GFP), pSR8.010 (8.010), or pSR6.067 (6.067) against wild-type (WT) strain. Sample
OD600 values were obtained at 10x culture suspension and then back-calculated for RFU/OD
results. Deviation (Dev.) in emission results are for triplicates of same sample in microplate wells
or quadruplet for PBS blank. Samples were either induced (ind-) with 0.5 mM IPTG or noninduced (non).
3.2 DC3000:pSR8.017; Analysis of DC3000 Harboring pSR8.010 and pSR8.017 Plasmids
Plasmid pSR8.017 was designed using the T5 promoter region for expression of M.
jannaschii tyrosyl-synthetase evolved to charge BpF onto the cognate tRNACUA. Plasmid
pSR8.017 (pML123.T5.BpFRS) then used to co-transform DC3000:pSR8.010 for growth in
liquid media in presence of IPTG +/- 0.1 mM BpF for fluorescence analysis (Table 11).
Induction under influence of BpF produced higher fluorescence (ind+; 2620 RFU/OD)
than without BpF (ind-; 2020 RFU/OD) or non-induced cells (non; 1840 RFU/OD). This
experiment shows the two plasmid system works as expected for the M. jannaschii TyrtRNACUA/BpFRS pair in P. syringae DC3000 and full-length GFPuvN149-BpF was later purified
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by affinity chromatography and fractions were analyzed by SDS-PAGE and Western blot
(Figures 26, 27, respectively).

Figure 17: Genehog cells featuring ligation product for pML123 (v-only; left) and BpFRS insert
(v+i; right) to show efficiency of DNA recombination reaction. Cells were plated to KB-T/Gen10
agar plates.
Sample
Blank
DC WT
DC:pSR8.017 non
DC:pSR8.017 ind-

RFU
Dev.
RFU/OD Dev.
Reported Dev.
-0.02333 0.202704 ---0.05
--469.8958 49.64479
470.
--468.0476 21.28055
468
--427.9028 100.5467
428

0.15
49.7
21.3
101

Table 10: Average of duplicate trials for cell fluorescence of DC3000:pSR8.017 (BpFRS-only)
induced with 0.5 mM IPTG (ind-) or non-induced (non) to show strains maintain native
fluorescence. Samples were analyzed in concert with wild-type DC3000 strain (DC WT).

Blank
WT
8+8 non
8+8 ind8+8 ind+

Sample
Blank
WT
8+8 non
8+8 ind8+8 ind+

RFU
Dev.
RFU/OD Dev.
Reported Dev.
-0.04667 0.143965 ---0.05
--568.2639 173.9573
568
--1844.667 638.193
1840
--2020.419 618.8777
2020
--2617.432 546.4868
2620

0.14
174
638
619
547
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Table 11: Average of fluorescence data for three trials for DC3000:pSR8.010:pSR8.017 (8+8).
All cells were induced with 0.5 mM IPTG, where applicable, and with 1 mM BpF (ind+) or
without (ind-) or non-induced (non). Cell cultures were grown for 44-48 hours post-induction.
Cell densities were either between 0.8 and 1.2 OD600 or normalized to OD600 0.1 for analysis.
Because DC3000 transformants featuring BpF-specific synthetase (BpFRS) exhibited
higher fluorescence of cultures induced with both IPTG and 1 mM BpF (ind+) over IPTG-only
induced (ind-) and non-induced (non) cultures (Table 11), additional confirmation was obtained
by the induction and growth of 28 mL DC3000:pSR8.010:pSR8.017 cultures for 48 hours at 30
o

C, 250 rpm and subsequent purification of full-length GFPuv N149BpF mutant protein. These

results are shown in SDS-PAGE (Figure 23) and Western blot detection images (Figure 24).
3.3.1 pML123.T5-TyrRS WT (pSR8.037) and pML123.T5-AzFRS (pSR8.044)
Further investigation into the capability of this dual plasmid system included growth of
DC3000:pSR8.010 strain subsequently transformed with plasmids containing M. jannaschii
wild-type Tyr-RS (pSR8.037) or the evolved synthetase, AzFRS (pSR8.044), which recognizes
the p-azido-phenylalanine crosslinking amino acid.
Constructs were prepared from in-house plasmids as above for the BpFRS and
transformation into P. syringae DC3000 and E. coli Genehog cells yielded viable colonies for
liquid culture growth at 36 or 48 hours. Results shown in the following tables include initial
fluorescence measurements of 36-hour cultures of DC3000 with tRNA and wild-type TyrRS
(Table 12), multiple-trial experiments to compare fluorescence for TyrRS and AzFRS in 36-hour
cultures of DC3000 (Table 13), and 48-hour DC3000 cultures expressing AzFRS alongside tRNA
(Table 14). Complimentary fluorescent studies were done in E. coli Genehog cells transformed
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with tRNA and BpFRS or AzFRS to compare effectiveness of the two evolved synthetase
proteins (Table 15).
DC3000 36/48 Samples (36 hrs 30 oC; 48 hrs 4 oC)
RFU
Dev.
OD
RFU/OD Reported
PBS
-0.11111111 7.149204 N/A
N/A
N/A
DC WT
42.6666667 11.0227
0.10
426.67
427
TyrRS non 175.222222 11.3002
0.10 1752.22
1750
Tyr 268.166667 13.80459
0.10 2681.67
2680

Table 12: Single trial fluorescence readings for DC3000 cell pellets featuring pSR8.010 and
pSR8.037 as non-induced (TyrRS non) and IPTG-induced (Tyr-) over 36-hour period. Deviation
(Dev.) is shown for multiple analysis of same culture sample in microplate wells. As samples
were normalized to OD600 = 0.1 for analysis.
Sample
Blank
DC WT
Tyr non
Tyr ind AzF non
AzF ind AzF ind +

RFU
-------

Dev.
RFU/OD Dev.
Reported Dev.
0 0.111111 --0
-508.8889 252.1317
509
-2697.407 25.10062
2700
-2304.074 423.2915
2300
-2294.815 253.4024
2290
-2345.185 364.2027
2350
-1760.37 176.192
1760

0.11
252
25.1
423
253
364
176

Table 13: Average of fluorescence readings over three trials for DC3000:pSR8.010:pSR8.044
(AzFRS) cultured over 36 hours P.I. in concert with DC3000 wild-type (DC WT), as well as
DC3000:pSR8.010:pSR8.037 (Tyr). Cultures for transformed strains were either non-induced
(non), IPTG induced (ind-) or induced by IPTG and 1 mM AzF (ind+).
Sample
Blank
DC 48
010+AzF 48 n
010+AzF 48 010+AzF 48 +

OD600
ODfluor
RFU
Dev.
RFU/OD Reported
N/A
N/A
0
7.483 N/A
0
4.40
0.10
76.500
12.951
765
765
1.50
0.10 271.917
28.468 2719.167
2720
2.30
0.10 233.917
11.859 2339.167
2340
1.60
0.10 192.917
13.201 1929.167
1930

38

Table 14: Single trial fluorescence reading for DC3000:pSR8.010:pSR8.044 (010+AzFRS)
cultured over 48 hours P.I. in concert with DC3000 WT. Cells cultures were either non-induced
(n), IPTG induced (-) or induced by IPTG and 1 mM AzF (+). Deviation (Dev.) is shown for
multiple analysis of same culture sample in microplate wells.
Genehog 8+8 (T5.AzF or BpF RS), 19 hours 37 oC, 25 hours 4 oC
Sample
RFU
Dev.
OD
RFU/OD Reported
PBS
0.111
26.770 N/A
N/A
N/A
AzF non
36.556
7.468
0.10 365.556
370
AzF ind 39.222
15.619
0.10 392.222
390
AzF ind +
68.444
8.904
0.10 684.444
680
BpF non
65.000
37.620
0.10 650.000
650
BpF ind 41.222
17.563
0.10 412.222
410
BpF ind +
117.444
25.006
0.10 1174.444
1200

Table 15: Fluorescence analysis of Genehog cells expressing pSR8.010 and pML123 plasmids
containing BpF and AzF synthetase shown as non-induced (non), IPTG-induced (ind-) or IPTG
and UAA induced (ind+). Test suggests functional tRNA/RS pairs in Genehog strain as per
increased fluorescence with ind+ > ind-.
Initially, DC3000: pSR8.010: pSR8.044 (AzFRS) strains did not show significant
fluorescence in cells or in supernatant fractions (Table 13). In fact, cells induced with IPTG in
presence of showed lower RFU/OD values than non-induced or IPTG-induced cultures. It was
considered that because p-azido-L-phenylalanine contains an azide bond able to undergo lightinduced reduction to p-amino-L-tyrosine, AzFRS could not to charge this degradation product to
the cognate tRNA. To confirm this possibility an additional growth test was performed with all
flasks wrapped in aluminum foil for the duration of the experiment. As expected, Table 16 shows
transformed DC3000 cultures in presence of both IPTG and AzF produced nearly two-fold the
fluorescence of IPTG-only or non-induced cultures. Therefore, it is shown that the dual plasmid
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system using the modified M. jannaschii Tyr-tRNACUA in concert with the corresponding AzFcharging synthetase yields successful incorporation of p-azido-L-phenylalanine to give full-length
fluorescing GFPuvN149-AzF. There was no attempt at purifying GPFuvN149-AzF for
visualization on SDS-PAGE or by Western blot detection from this final aluminum foil covering
experiment. Future studies with AzF should allow for foil or other light-blocking covering.
Sample
Blank
Non
IndInd+

ODfluor
N/A
0.1
0.1
0.1

RFU
0.333333
54.5
64.5
125.2

Dev.
RFU/OD Reported Dev.
9.626353 N/A
0.333
9.63
9.949874
545
545
9.95
14.59795
645
645
14.6
17.25399
1252
1250
17.3

Table 16: Duplicate DC3000:pSR8.010:pSR8.044 cultures were foil-covered and grown for 42
hours at 30oC before setting at 4oC for an additional 20 hours. Cultures were diluted to OD600 0.1
for fluorescence analysis of non-induced (non), IPTG-induced (ind-), and IPTG with AzF (ind+).
This thesis has shown that the unnatural amino acids, BpF and AzF (Figure 18), can be
utilized in vivo by P. syringae DC3000 containing an exogenous tRNA/RS pair to suppress the
TAG stop codon and produce full-length reporter proteins. It was noted that the levels of
fluorescence were not as high as expected in DC3000 and so the GFPuvN149TAG plasmid
(pSR8.010) and the plasmid pair including the wild-type TyrRS in E. coli NEB5α F’ cells was
performed to attempt further characterizing of the this system’s effectiveness. NEB5α F’ cells
(New England Biolabs) contain suppressor tRNA, supE44, are able produce full length
GFPuvN149TAG proteins with an installed glutamine (Singaravelan, 2010). Although results
showed expected increased fluorescence (Table 17, Table 18) they also confirmed that the system
was producing lower fluorescence in all organisms. It was decided to alter the promoter
sequences for the tRNACUA in attempt to increase the productivity of this dual plasmid system.
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Figure 18: Crosslinking phenylalanine derivatives investigated in this study for incorporation
into TAG stop codon sites by M. jannaschii Tyr-tRNA in presence of evolved cognate M.
jannaschii TyrRS synthetase: AzF (left) or BpF (right).
NEB5α F' with pSR8.010 only (19 hours 37 oC, 25 hours 4 oC)
Sample
RFU
Dev.
OD600
RFU/OD Reported
PBS
2.778
6.671 N/A
N/A
N/A
non
12.000
5.585
0.10 120.000
120
ind 23.556
10.277
0.10 235.556
240

Table 17: Fluorescence analysis of NEB5α F’ cells expressing pSR8.010. Test shows
functionality of GFPuv N149TAG under IPTG-induced (T5) promotion for fluorescence of ind- >
non.
NEB5α F' :pSR8.010:pSR8.037 (19 hours 37 oC, 25 hours 4 oC)
Sample
RFU
Dev.
OD600
RFU/OD Reported
PBS
0.222
7.190 N/A
N/A
N/A
8+8 (Tyr) non
160.667
8.958
0.10 1606.667
1600
8+8 (Tyr) ind 292.333
15.827
0.10 2923.333
2900

Table 18: Fluorescence analysis of NEB5α F’ cells expressing pSR8.010 and pSR8.037. Test
shows successful working of dual plasmid system that includes TyrRS WT (8+8 (Tyr)) as
fluorescence for IPTG-induced (ind-) is greater than non-induced (non).
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3.4 New Mj. Tyrosyl-tRNA Promoters: lpp and proK

Figure 19: DNA gel for plated cells of pBBR-GFPuvN149 (v; top left) with either lpp cassette
(+lpp; bottom) or proK cassette (+proK; top-right).
A single trial time-point experiment was performed to test if there was increased
transcription of Tyr-tRNA and therefore heightened fluorescence of full-length GFPuv N149BpF
mutant protein. Cell-based fluorescence results did not show that promoter, proK, gave any
higher RFU for samples induced by IPTG and BpF. After the first trial, no more studies into the
proK promoter cassette were performed. Initial results for the lpp promotion cassette showed
promise and subsequent trials were performed to give varying results. It was noted that when
cells fluoresced greater for IPTG and UAA-induced samples these values seemed slightly higher
than for the tRNA-met-3 promoter-based plasmids. A higher amount of protein was therefore
purified form 28 mL cultures to compare the tRNA-met-3 cassette and the lpp cassette.
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72 hrs 30 oC, 20 hrs 4 oC
96 hrs. 30 oC, 20 hrs. 4 oC
120 hrs. 30 oC, 20 hrs. 4 oC
RFU/OD Dev.
Reported Dev. RFU/OD Dev.
Reported Dev. RFU/OD Dev.
Reported Dev.
Blank
---0.26 0.11 --0.00
0.11 --0.00 0.11
DC WT
2218.889 -2220 -3826.667 -3830 -5585.556 -5590 -DC:lpp:BpF non
1887.037 767.866
1890
768 3184.097 11.490
3180
11.5 2942.546 936.065
2940
936
DC:lpp:BpF ind2019.506 250.543
2020
251 3354.653 220.283
3350
220 5026.944 956.558
5030
957
DC:lpp:BpF ind+ 3128.796 1026.156
3130 1030 4362.583 1264.071
4360 1260 3349.753 454.469
3350
455
Sample

Table 19: Average fluorescence of cells over 4 trials for DC3000:pSR8.052.1:pSR8.017
(DC:lpp:BpF) against wild-type DC3000 (DC WT). Cultures for transformed cells were either
non-induced (non), IPTG-induced (ind-), or induced with IPTG and 1 mM BpF (ind+). Although
two samples showed increasing fluorescence in the order of ind+ > ind- > non, the other two
cultures did not showed ind- > ind+.
Based on the fluorescence results, combined with lack of detection by Western blot
(Figure 27), it is noted that the lpp promoter cassette did not augment GFPuvN149 expression. In
fact, the only tRNA promoter system to give successful incorporation of BpF into GPFuvN149 is
for the native P. syringae DC3000 as found in vector pSR8.010 (Figure 26, 27, 28).
3.5.1 Investigating Secretion of Full-length GFPuv N149 Mutants in Liquid Culture
During a replicate trial for DC3000:6.067 (Pyl-tRNA, GFPuv N149TAG), there appeared
a greenish-glow in the liquid cultures after cell pellet collection, after a period of 120 hours. This
fluorescence suggested there was significant full-length GFPuv in the culture supernatant that
could be seen by eyesight. In presence of 365 nm light, even non-induced liquid sample featured
a more intense green fluorescence. Therefore, it was decided to test other strains with tRNA and
GFPuv N149TAG only, as well as DC3000 wild-type and DC3000 expressing the GFPuv WT.
Subsequent observance of GFPuv WT fluorescence in the culture supernatant lead to culture
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other DC3000 strains to see if cell-pellet based fluorescence results could be supplemented by
any full-length GFPuv N149 mutants lost to the culture broth.
Attempts to normalize relative fluorescence of sample supernatants failed due to (a)
inconsistent homogeneity of collected time-points which could not always be remedied by
pipetting of solution, and (b) negative values of A280 (mg/mL) readings against KB-T as a blank
for various time-points. Eventually, as no samples except the GFPuv WT cultures provided Histagged proteins under Western blot detection, the inability to normalize liquid culture samples is
not seen as a severe problem in this study.
However, it was regarded that wild-type DC3000 secretes small molecules, especially
siderophores such as pyoverdin (Jones, 2007), and other molecular bodies that possess
fluorescence. To account for this, liquid cultures of wild-type DC3000 samples at given timepoints were analyzed for fluorescence. Finally, a series of analyses for KB-T broth with added
tetracycline at 10 µg/mL acts as an additional corrective factor for the supernatant cultures with
GFPuv (WT or N149TAG) and tRNA vector.
To observe if full-length GFPuv N149 mutants were expressed and secreted into culture
milieu, samples were analyzed over several days post-induction. All time-points were taken from
the same initial induced culture. Fluorescent analysis featured multiple reads on same sample as
load to two or three wells in microplate. These triplicates were necessary as incident irradiation
of GFPuv causes quenching and reduced fluorescence in second and later exposures. Culture
supernatant samples were excited at 390 nm with emission detection at 510 nm as for cells.
To detect any full-length GFPuv mutants in the liquid supernatant, cultures were induced
and incubated from 48 to 120 hours. Liquid culture supernatant fractions were analyzed by
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fluorescence assay. Tetracycline in KB-T was additionally analyzed during intermittent
fluorescence reads to obtain average emission for antibiotic at 510 nm of 670. +/- 239 RFU; this
value is not featured in correction unless otherwise noted.
Interestingly, there was a consistency for IPTG-only induced cultures showing higher
supernatant fluorescence than IPTG with UAA fluorescence for strains, DC3000:pSR6.067 +/PylRS (WT or Y348F) and DC3000:pSR8.010 +/- RS (TyrRS WT, BpFRS or AzFRS), as well as
strains featuring alternative tRNA promoters, lpp and proK. To further confirm no GFPuvN149
mutants were being secreted into the liquid culture, Western blot detection against 6xHis antibody
was performed and the resulting images are shown in Figures 21-25.
3.5.2 Purification of GFPuv WT from DC3000 Supernatant
GFPuv WT has been expressed in DC3000 and was secreted into the media. GFPuv WT
was purified from combined supernatant fractions (48, 72, 96-hours P.I.) and visualized on SDSPAGE gel (Figure 20). Fractions featuring GFPuv WT were combined, concentrated, and later
used as loading control for GFPuvN149 mutant analysis in transformed strains.
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Figure 20: SDS-PAGE results for GFPuv WT purification from DC3000 liquid media. Protein
began significant elution at 50 mM imidazole (W2-1) showing an expected 27.8 kD band,
equivalent to full-length GFPuv-6xHis. (Lanes annotated as left to right: 1, empty; 2, protein
ladder; 3, 500 mM imidazole wash fraction; 4, 100 mM imidazole wash fraction; 5, 74 mM
imidazole wash fraction; 6, 50 mM imidazole wash fraction part 2; 7, 50 mM imidazole wash
fraction part 1; 8, 25 mM imidazole wash fraction part 2; 9, 25 mM imidazole wash fraction part
1; 10, 3x flow-through (FT) fraction).
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3.5.3 GFPuv WT Western Blot Analysis

Figure 21: Western blot membrane showing GFPuv products recognized by 6xHis antibody.
Time-points are for hours post-induction in DC3000 culture expressing either GFPuv WT, GFPuv
N149 TAG along with Mb. Pyl-tRNA (6.067), or none (WT). GFPuv WT-6xHis is 27.8 kD in
size and is the prominent band in the five right-hand lanes. No His-tagged GFPuv N149 mutant
was seen in combined wash fractions from 6.067. (Lanes can be annotated as left to right: 1,
pre-stained protein ladder; 2, 6.067 concentrated purification fraction 3 and 4; 3, 6.067
concentrated purification fraction 50 mM imidazole; 4, pre-stained protein ladder; 5, DC3000
WT 120-hour culture supernatant; 6, combined 120-hour DC3000:GFPuv WT supernatant; 7,
DC3000:GFPuv WT 96-hour IPTG-induced supernatant; 8, DC3000:GFPuv WT 96-hour noninduced supernatant; 9, DC3000:GFPuv WT 72-hour IPTG-induced supernatant; 8,
DC3000:GFPuv WT 72-hour non-induced supernatant).
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3.6.1 Western Blot for 6.067
As supplement to previous fluorescence studies, Figure 21, lanes 2 and 3, shows
concentrated fractions of purified supernatants from DC3000:6.067 96-hour induced and
incubated cultures did not reveal 6xHis-tagged protein.
3.6.2 Medium-scale (25 mL) DC3000:6.067 Purification
It was plausible that a higher cell density of DC3000:pSR6.067 IPTG-induced culture
could produce a significant amount of full-length GFPuvN149 mutants. Purification and
concentration of 25 mL supernatant for 96-hour incubated IPTG-induced DC3000:6.067 was
performed and examined by Western blot. However, there was no detected full-length GFPuv
N149 mutant, suggesting that the original liquid culture fluorescence observation was not
GFPuvN149 dependent.
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Figure 22: Western blot for detecting full-length GFPuv mutant in DC3000:6.067 purification
fractions alongside GFPuv WT loading control (27.8 kD). Lane order, left to right: 1, prestained marker; 2, DC3000:pSR6.067 25 mL ind- purification fraction; 3, DC3000:pSR6.067
non-induced fraction; 4, GFPuv WT control.
There was no further investigation into the fluorescence of the DC3000:pSR6.067 strain
and it was therefore assumed that the intensity of green tint to the liquid cultures that had inspired
this supernatant-based inquiry was due solely to small molecules produced by DC3000 in the KBT broth. It was still necessary to examine others cultures for GFPuvN149 in culture supernatant.
3.7 Western Blot for 96-hour Culture Liquids Media
Because it was seen that wild-type GFPuv was produced in cells and even secreted in
high amounts into the liquid media, it was considered that any full-length GFPuv N149-UAA
could also have been secreted into the milieu and therefore the cell-based fluorescence screening
would not accurately represent the level of mutant GFPuv expression. It was necessary to grow
DC3000 strains as induced +/- unnatural amino acids over the same time-course for the wild-type
GFPuv-expressing strain. All cultures were prepared as above and grown for 5 days, as
mentioned above. Liquid media samples at 96- and 120-hour time-points were analyzed by
Western blot. However, there was no indication that any samples besides the DC3000:GFPuv
WT expression strain secreted any full-length GFPuv N149 mutants. It should be noted that the
AzFRS transformants (pSR8.010:pSR8.044) were not wrapped in foil for this experiment.
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Figure 23: Western blot for nitrocellulose membrane showing select 96-hour post-induction
samples from DC3000 strains. Only the pre-stained protein ladder and the GFPuv WT load
control (27.8 kD) feature apparent bands, suggesting there was no full-length GFPuv N149
mutants being secreted into the culture. Loading pattern (left to right): 1, DC3000 WT (DC WT)
96-hour culture broth; 2, DC3000:pBBR1MCS3-GFPuv N149TAG non-induced; 3,
DC3000:pBBR1MCS3-GFPuv N149TAG ind- (IPTG induced); 4, DC3000:pSR8.010 noninduced; 5, DC3000:pSR8.010 ind- (IPTG induced ); 6, DC3000:pSR8.052.2 non-induced; 7,
DC3000:pSR8.052.2 ind- (IPTG induced); 8, DC3000:pSR8.010:pSR8.044 non-induced; 9, ind(IPTG only); 10, ind+ (IPTG + 1 mM AzF); 11, pre-stained protein ladder; 12, GFPuv WT
control; 13, empty.
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3.8 Western Blot for DC3000:pSR8.010: pSR8.017 and DC3000:pSR8.052.1: pSR8.017
Fluorescence assays routinely showed expected results of increased fluorescence with
unnatural amino acid addition of p-benzoyl-L-phenylalanine (BpF). It was therefore necessary to
ensure that no full-length GFPuv N149BpF mutants were being secreted into the liquid culture.
Western blot detection of 96- and 120- hour cultures did not show any 6xHis-tagged proteins in
those fractions, as compared with the loading control, GFPuv WT-6xHis which was purified
directly from DC3000:GFPuv WT supernatant fractions. This confirms that is no full-length
GFPuv N149BpF mutant being secreted. It is possible that there is either (a) truncated GFPuv
N149TAG polypeptides being secreted, or (b) full-length GFPuv N149 mutants with a cleaved
6xHis-tag, but these are both unlikely as (a) truncated GFPuv would have to be formed in very
high amounts before being secreted and (b) the probability of selective removal of the C-terminal
His-tag would still suggest that supernatant fluorescence values would still be very high even if
protein could not be detected by Western blot.

Figure 24: Western blot nitrocellulose membrane showing results from
DC3000:pSR8.010:pSR8.017 non-induced (n), IPTG-induced (-) and IPTG-induced with 1 mM
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BpF (+) in 96 and 120-hour culture supernatants. Only the GFPuv WT load marker (27.8 kD)
and the pre-stained protein ladder feature any band appearance, suggesting there was no fulllength GFPuv N149 mutants being secreted into the culture. (Lane order, left to right: 1, 96 hrs.
non-induced; 2, 96 hrs. IPTG-induced; 3, 96 hrs. IPTG and BpF induced; 4, 120 hrs. noninduced; 5, 120 hrs. IPTG-induced; 6, 120 hrs. IPTG and BpF induced; 7, pre-stained ladder; 8,
GFPuv WT control; 9, empty lane; 10, empty lane.

Figure 25: Western blot nitrocellulose membrane showing results from
DC3000:pSR8.052.1:pSR8.017 non-induced (non), IPTG-induced (ind -) and IPTG-induced with
1 mM BpF (ind +) in 96 and 120-hour culture supernatants. Only the GFPuv WT load marker
(27.8 kD) and the pre-stained protein ladder feature any band appearance, suggesting there was
no full-length GFPuv N149 mutants being secreted into the culture. Lane order, left to right: 1,
96 hrs. non-induced; 2, 96 hrs. IPTG-induced; 3, 96 hrs. IPTG and BpF induced; 4, 120 hrs.
non-induced; 5, 120 hrs. IPTG-induced; 6, 120 hrs. IPTG and BpF induced; 7, pre-stained
ladder; 8, GFPuv WT control; 9, empty lane; 10, empty lane. Position of lanes shown on
membrane are approximate for samples without apparent bands.
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3.9 Mid-scale Culture for DC:pSR8.010:BpFRS, DC:8.052.1: BpFRS
Purification of GFPuv N149BpF protein from 50-hour incubated induced DC3000 cultures
featuring the evolved BpFRS and the corresponding M. jannaschii Tyr-tRNA with either the
tRNA-met-3 or the lpp promotor cassette was performed.

Figure 26: 15% SDS-PAGE gel showing purification fractions of GFPuv N149BpF from
DC3000:pSR8.010:pSR8.017 featuring tRNA-met-3 promoter. Full-length GFPuv N149 mutant
is shown in lanes for W2-1, W2-2, W3-1, and W3-2. Lane order, left to right: 1, 3x flowthrough; 2, W1-1 (25 mM imidazole); 3, W2-1 (50 mM imidazole); 4, W2-2; 5, W3-1 (75 mM
imidazole); 6, W3-2; 7, W4-1 (100 mM imidazole); 8, W5 (500 mM imidazole); 9, GFPuv WT
control; 10, unstained protein ladder.
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Figure 27: Western blot nitrocellulose membrane showing purification fractions of GFPuv
N149BpF from DC3000:pSR8.010:pSR8.017 (010+BpF) and DC3000:pSR8.052.1:pSR8.017
(lpp+BpF). Full-length GFPuv (WT or N149BpF) features 6xHis-tag and is appears for GFPuv
WT control (27.8 kD) and 010+BpF wash fractions 2, 3, and 4. Lane order, left to right: 1, prestained ladder; 2, lpp+BpF W4-1; 3, lpp+BpF W3-1; 4, lpp+BpF W2-1; 5, lpp+BpF W1-1; 6,
GFPuv WT control; 7, 010+BpF W4-1; 8, 010+BpF W3-1; 9, 010+BpF W2-1; 10, 010+BpF
W1-1.
Expression of GPFuvN149BpF from P. syringae DC3000 has been shown in both
fluorescence studies and protein purification (Table 11, Figure 27). In addition, fluorescence data
from Table 16 shows that GFPuvN149AzF full-length protein can be expressed in DC3000.
Therefore, it is reasonable to suspect other unnatural amino acids – recognized by other evolved
M. jannaschii tyrosyl-synthetase – could be incorporated in P. syringae DC3000 using this
system. These results are proof of the success of the present invention for incorporation of
unnatural amino acids in the plant pathogen
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3.10 Further Increasing the Efficiency of Working Parts
It should be possible to increase expression of the synthetase in plasmid pML123 by
substituting for the T5 promoter and terminator regions with the neomycin promoter and
terminator sequences to flank the synthetase insert. It was shown by Labes, et al. in 1990 that the
neomycin promoting cassette yields very high protein expression for β-galactose in soil bacteria
and lower expression levels in E. coli (Table 20). This could be suitable for studies involving
molecular probes, although effector studies may require weaker promotion.
Plasmid
(promoter)
pML122lac (pNM)
pML130lac (plac)
pML132lac (tac)
pML140lac (pS1)
without plasmids

E. coli
βGal
1400
2000
11300
40
16

Nm
R
R
R
S
S

R. meliloti
βGal
21800
9050
2850
3300
110

Nm
R
R
R
R
S

R. leguminosarum
βGal
13900
6250
1150
1200
130

Nm
R
R
R
R
S

P. putida
βGal
16300
9800
2950
3350
150

Nm
R
R
R
R
S

Table 20: βGal activities and NmR gene expression of vectors carrying the lacZ and NmR genes in
Gram- hosts. Literature reference featured neomycin (Nm) at 100 μg/mL working concentration;
βGal units are as Miller units. (R, resistant; S, susceptible; adapted from Labes, 1990; Table II).
Another promoter to considerably enhance the expression of biomolecules (reporter,
synthetase, and even effector proteins) for this UAA incorporation system is the Amaranthus
hybridus chloroplast promoter, PpsbA, as found in plasmid pDSK-GFPuv (Wang, 2007). This
plasmid was designed for mobility and attachment assays of phytopathogens in planta, especially
for the use of mutated GFPuv proteins as biological probes in plant pathogens and their hosts.
Indeed, pathogen-expressed probe/effector fused to a Type III secretion signal would be greatly
benefitted by use of such a strong promoter. As PpsbA is constitutive, in planta studies of
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infection may have to be optimized against for severe overexpression of particularly active
effector proteins – a dead specimen is not as good for study as one surviving.

Figure 28: Plasmid map of pDSK-GFPuv featuring GFPuv under promotion of psbA chloroplast
promoter (PpsbA) and T7 gene10 ribosome binding site (RBS). {Retrieved from Wang, 2007}
3.11 Secretion of GFPuv WT from DC3000, Revisited
One unexpected result of this study shows that overexpression of the wild-type GFPuv
protein in DC3000 produces a GFPuv-dependent fluorescent supernatant that emits differently
than any siderophore-based fluorescence produced by the strain. This process appeared even
within 48 hours of GFPuv expression in the bacteria, suggesting the GFPuv was likely due to
protein secreted from live bacteria, whether than being the residual molecular species from
culture-contained burst cells. As the live bacteria pellets also showed fluorescence, it is likely
there is a maximal expression amount that can exist within the organism before subsequent
secretion of full-length protein into the culture broth. It is also reasonable to suspect the GFPuv
content of the liquid, just as in the cells, was not as aggregation and was fully-folded, as nonfolded and aggregated forms of GFP (and most likely GFPuv) do not fluoresce (Heim, 1994;
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Tanudji, 2002). This secretion event was likely to keep the intracellular compartments from
bursting under increasing cellular stress at longer time-points. Incidentally, it was also observed
(data not shown) that liquid culture supernatants for DC3000:GFPuv WT showed increased
fluorescence over DC3000 wild-type in LB media – a richer nutrient broth that would therefore
negate any mineral deficiencies for the bacterial strain and thereby making repressing the usual
secretion of metal-chelating siderophores. This occurred even after 1.5 hours post-induction
(data not shown), and further supports the possibility that GFPuv was not being released by dead
bacterial cells. It has not been determined by what method these GFPuv WT proteins were being
secreted, although it can be assumed the process does not involve virulence-based Type III
secretion system (T3SS) as the GFPuv WT protein did not feature a T3SS signal motif, nor did
the GFPuv WT contain any other secretion-related peptide signals. Further insight into this
process would require very strong expression of the GFPuv N149-BpF mutant, with which one
could instigate UV-induced crosslinking of the mutant protein to covalently attach to its exporting
protein partner(s). Additionally, if a high concentration of expressed proteins, such as antibiotic
resistance proteins not needed for environmental survival, were to be present at high levels in the
supernatant, then there may be further interest in using P. syringae DC3000 as a lower
temperature organism for production of biomolecules for research or educational resources. An
example experiment would include transformation of DC3000 cells with a plasmid containing
both kanamycin and gentamycin acetyltransferase, but for the transformants to be grown only in
gentamycin liquid stock. Presumably, protein electrophoresis or more sensitive blotting
techniques (e.g. for kanamycin fused to a 6xHis-tag and induced by IPTG) would quantify any
supernatant-localized secreted proteins.
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3.12 Possible Role of P. syringae pv. tomato DC3000 as Resource for Primary, Junior, and
Secondary Education
Given the easy acquisition of GFPuv from the culture media, it is also likely that other
proteins over expressed in DC3000 may be secreted into the liquid media, thus allowing a nearly
continuous supply of expressed protein in the supernatant that could be purified by various
methods. This supernatant-extraction process could be considered especially useful in
laboratories lacking sufficient lysis methods – including primary, middle, and secondary school
science labs. Indeed, this would also allow for such small laboratories experiments to have no
need of toxic chemicals such as phenol and chloroform, caustic or heavy denaturing agents, or
sonication or pressurized-lysis instruments. It has not been observed that strains of E. coli K-12
cells expressing GFPuv will secrete this full-length protein into their liquid culture a without
specialized secretion signals (Mergulhao, 2005) or selective permeation (Penna, 2002). DC3000,
therefore, can be considered a less time-involved species for producing some biological products.
Consequently, because P. syringae pv. tomato DC3000 is not a human pathogen and is
not suited for epiphytic survival, and because the species can grow at a range of temperatures,
from 4 oC to 30 oC, room temperature cultures can be incubated on older model shakers and even
on sterilized bench, allowing financially-burdened or frugal laboratories to study microbiological
techniques with little need of expensive incubation chambers. Protein purification would be
facile for younger students as this particular strain expressed a GFPuv WT with a terminal 6xHistag. After collecting supernatant samples, students could gain practice of purifying proteins and
build an understanding of useful analytical techniques. For GFPuv, specifically, subsequent
study of the fluorescence due to proper protein folding at differing pH levels, temperatures or in
differing chaotropic agents, such as urea or other amines will help the students understand how
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protein activity (analogizing enzymes to fluorescent proteins) is dependent upon specific
environmental factors. Finally, should one possess strains that can produce inexpensive mutant
GFPuv biological probes, this would allow students to use such tools to understand more of the
complex chemistry occurring in biological systems. Regardless, these characteristics – for wildtype GFPuv or mutants – also enable students to study the bacteria and the plant host (e.g. S.
lycopersicum or A. thaliana) interactions, for both the tomato plant and the Arabidopsis can be
easily grown in a make-shift, moderately sterilized laboratory area.
3.13 Expanding the Usefulness of the Present Invention
Although the direct feature of this plasmid system relates to using the benzophenone and
azido derivatives of phenylalanine, other unnatural amino acids can be incorporated given the
properly-evolved synthetase. In literature to date, there have been a large number of UAAs
constructed, any of which could ideally be featured in formed mutated proteins – proteins that
could not only capture host cell targets or partners within the bacteria itself (e.g. transcription
factors or scaffold and transporter proteins), but also for study of cellular dynamics, such as freeflow of molecular species in situ or redox-related changes using a reporter protein capable of
losing fluorescence, quantitatively, in presence of hydrogen peroxide, hydrogen sulfide, ionic
mineral concentrations (Fang, 2012; Niu, 2013), nitric oxide, or other signaling molecules. In
addition, in situ studies are not limited to using a specialized form of the GFPuv protein as a
biological probe. This current study was developed with the intent of incorporation crosslinking
amino acids, notable BpF and AzF, into secreted effector proteins and capturing their host targets
during the natural infection process of the P. syringae pv. tomato DC3000 phytopathogen and A.
thaliana or S. lycopersicum. However, this thesis work can be extended to other organisms.
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There are over 50 pathovars of P. syringae, alone (Xin, 2013), and it is expected that the
present dual plasmid system is applicable direct study of these pathovars with their individual
hosts. This would be especially beneficial for species such as bean pathovar, P. syringae pv.
syringae B728a, which is a model pathogen for study of epiphytes’ sensing of the extra-host
environment (UV, wind, temperature). With an alteration of either the tRNA or the synthetase
species, this UAA-incorporation system can be used for study in other plant pathogenic bacteria.
The two parent plasmids used in this system are characteristically broad-host range bacterial
expression plasmids. Notable prokaryotes for study include Erwinia spp., Xanthomonas spp.,
Rhizobium spp. (Hueck, 1998), or agriculturally-beneficial bacteria, such as Lysobacter
enzymogenes (Wang, 2013), and even Agrobacterium tumefaciens – peaking interest in both
pathogen-based and plant transformation studies. UAA-based modifications of L. enzymogenes
proteins should be easily accomplished by substituting the tRNA vector, pBBR1MCS3 (TetR)
with its chloramphenicol resistance marker counterpart, pBBR1MCS (Kovak, 1995), as this
bacteria is resistant to common antibiotics, excepting gentamycin and chloramphenicol (Wang,
2013). And certainly, successful use A. tumefaciens to transform plant species with UAAincorporating machinery would open a large field of biotechnological study.
Incorporation of UAAs into any of the above bacteria, for example, requires (a) no
significant TAG stop codon suppression tRNA native to the system -- although concerns on this
point are minimal (Povolotskaya, 2012), (b) that there is no suppression of other stop codons if
they are used less frequently than TAG, (c) a suitable pair of exogenous tRNA/RS, for example,
M. barkeri, or M. jannaschii, or other biological species (Chatterjee, 2012), orthogonal to the host
organism’s native translation machinery, (d) a species for study that is capable utilize the selected
unnatural amino acid, and (e) promoting cassette(s) optimal for yielding satisfactory expression
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of all exogenous molecules without causing unnecessary toxicity to the bacterium or, if
applicable, the later infected host. For most requirements the methods will be similar to what has
been described herein. This thesis can therefore be a starting guide to produce a set of optimized
working components for the incorporation of unnatural amino acids for study of intracellular and
extracellular environmental events such as bacterial-host molecular interactions and this basis of
disease.
This thesis presents the methods and resulting success for incorporation unnatural amino
acids into the model plant pathogen, Pseudomonas syringae pv tomato DC3000 – a task that had
not yet been performed – and thus produces a new tool for researchers to study the molecular
mechanisms involved in bacterial pathogen-host interactions.
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Chapter 4. Materials and Methods
4.1 Common Instruments and Hardware
Nanowater was provided from Barnstead Nanopure (Thermo Scientific); Isotemp 2320 water
bath, Nanodrop 2000, Precision incubation chambers, and MaxQ 8000 incubation shakers
(Thermo Fisher); digital analytical balances (Mettler Toledo); Manual single-channel pipettes
(Rainin; Mettler Toledo); pipet tips, polystyrene plates, analog vortex mixer, Digital Heat Block
(250 V), and hot plate/stirrer, 50 mL conical tubes, and electroporation cuvettes were purchased
from VWR; culture tubes, PCR tubes (0.25 mL), laboratory glassware, and additional 50 mL
conical tubes from Fisherbrand; Mastercycler thermocycler, Mini Spin Plus centrifuge,
Centrifuge 5424, and Electroporator 2510 (Eppendorf); Allegra X6-R bench-top model
(Beckman-Coulter); Axygen 0.6 mL and 1.5 mL centrifuge tubes (Corning); sonication of cells
performed with Model 120 Sonic Dismembrator (Fisher Scientific); and all images for DNA gels,
SDS-PAGE gels, agar plates, and Western blot colorimetric development of membranes were
obtained by GelDoc XR+ imaging system with ImageLab software (BioRad).
4.2 Bacterial Cell Preparations
4.2.1 Preparation of Liquid and Solid Culture Media: LB and KB-T
E. coli cells required use of lysogeny broth (LB) as prepared with LB broth media
(Teknova). LB/agar plates were prepared with additional of 15.0 g/L agar (Criterion by Hardy)
and, following autoclave sterilization of LB/agar mixture, appropriate working concentration of
antibiotics.
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P. syringae pv. tomato DC3000 cells required use of modified King’s B medium with
tryptone substituted for peptone. The modified medium contains 9 mM K2HPO4, 1.6 mM
MgSO4*7H2O, 1% v/v glycerol, pH 7.0, with added 2% w/w tryptone (Bacto; BD). KB-T agar
plates were prepared with additional of 18.0 g/L agar and, after autoclave sterilization,
appropriate working concentration of antibiotics.
It can be noted that P. syringae pv. tomato DC3000 is naturally resistant to both rifampin
(as per the genotype) and also chloramphenicol, presumably at concentrations less than 17
µg/mL. However, growth of wild-type strain was done without addition of any antibiotics.
All culture media reagents were purchased from Sigma-Aldrich unless otherwise stated.
MgSO4*7H2O was purchased from EMD Millipore. All nanowater was autoclaved before use.
4.2.2 Preparation of Chemical Competent Cells
Chemical competent cells were prepared in CCMB media and store at -80 oC until use.
CCMB media components: {CaCl2*2H2O (80 mM), MnCl2*4H2O (20 mM), MgCl2*6H2O (10
mM), potassium acetate (10 mM), glycerol (10% v/v), pH 6.4}; media was sterilized through 0.2
um filter (VWR) and stored at 4 oC. Reagents were purchased from Sigma Aldrich (CaCl2*2H2O,
MnCl2*4H2O, glycerol) and Fisher (MgCl2*6H2O and potassium acetate).
Chemical competent cells were prepared as follows: overnight inoculants were grown at
37 oC, 250 rpm before subculture into 100 mL LB. Subcultures were incubated to OD600 0.4 to
0.6, then cells were collected over two rounds of centrifugation {5000 x g, 10 min}. Broth was
decanted and cells were suspended in 1 mL CCMB media, collected as above, and recovered in 4
mL CCMB. Aliquots were prepared for storage in 1.5 mL or 0.6 mL tubes. In some
experiments, liquid ratios were fixed but volume was reduced.
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4.2.3 Transformation of Cells
All transformations for E. coli strains, Genehog, NEB5α (New England Biolabs), or
NEB5α F’ (Wei Niu, University of Nebraska-Lincoln), were performed via heat shock method for
chemical-competent cells stored at -80 oC. Plasmid DNA was added at 10%, or less, cell volumes
and set on ice for 10 minutes before incubated at 37 oC for 30 seconds, with return to ice for 1-2
minutes. Heat shocked cells were recovered with either 500 µL lysogeny broth for Genehog and
NEB5α transformations featuring Pyl-tRNA/RS system, or 10x initial cell volume of LB (for
Genehog cells featuring Mj. plasmids). Recovered cells were incubated at 37 oC, 250 rpm for
40-60 minutes in MaxQ 8000 shaker and then plated to pre-warmed (37 oC) LB/agar plates with
appropriate antibiotics and plated cells incubated in 37 oC for 1 or 2 days in incubation chambers
to obtain medium-sized colonies suitable for inoculation.
All P. syringae pv. tomato DC3000 transformations were performed via electroporation
using Electroporator 2510. Previous to electroporation, cells were swabbed from 30 oC-warmed
plates (1-60 days old) and suspended in 1 mL of cold (4 oC) 1 M HEPES, 10% glycerol (pH 6.8)
by vortexing on high and centrifugation at 4 oC, 16 200 x g, 1 minute. Cells were washed an
additional two times in cold 1 mL HEPES/glycerol buffer, each, and final pellets were suspended
by pipette in 60 µL on ice. Plasmid DNA was added at 4 µL for 60 µL washed cells and this
suspension was transferred to pre-chilled electroporation cuvette and kept on ice for 2 minutes
before 2500 V pulsing to obtain time constant values between 1.4 and 5.4, depending on cell
density in 60 µL suspension. Immediately after pulse, 400 µL of cold KB-T broth was added to
cuvette to recover cells, after which the volume was transferred to original 1.5 mL tube and set
into 30 oC, 250 rpm for one hour of incubation in MaxQ 8000 shaker. Incubated cells were plated
to pre-warmed (30 oC) KB-T/agar plates at 150 µL cells per plate and set for 1-3 days in 30 oC
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Precision chamber. It can be noted that for any time constant in the range given, plated cells
would generally grow well over an average 2-day period and plates featuring P. syringae DC3000
transformants will continue to grow in 4 oC refrigerator up to 6-months if there is ample solid
agar media for growth; colonies on these plates, however, will be yellowish-green in color, thick
in biofilm, and sticky.
Working concentrations of antibiotics included ampicillin (100 μg/mL), chloramphenicol
(34 μg/mL), kanamycin (50 μg/mL), tetracycline (10 μg/mL), and gentamycin (10 μg/mL). All
antibiotic solutions (as mg/mL) were stored at -20 oC until needed and returned to freezer after
use. Ampicillin, chloramphenicol, and tetracycline were supplied by Calbiochem; kanamycin
sulfate purchased from IBI Scientific; gentamycin was purchased from Teknova.
4.3 Recombinant DNA Methods
4.3.1 Plasmid DNA Miniprep
All plasmid DNA was purified from overnight cell cultures following manufacturer’s
protocol. Three different miniprep kits were used in house during the duration of this project.
For M. barkeri-related plasmids, PureYield Plasmid Miniprep Kit (Promega) was used, while for
M. jannaschii-related plasmids, Zyppy Plasmid Miniprep Kit (Zymo Research), excluding vector
pSR8.017, which was purified using GeneJET Plasmid Miniprep Kit (Thermo Scientific). All
plasmids were eluted in nanowater and DNA concentration tested at 260 nm with Nanodrop
2000.
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4.3.2 PCR Methods
All polymerase chain reaction (PCR) procedures utilized autoclaved nanowater (ddH2O), KOD
Hot Start Polymerase (KOD; EMD Millipore) and featured 30 cycle programs for denaturing,
annealing, and extension stages of reaction. Tables for reaction setup are shown in Appendix I.
4.4 Preparation of Unnatural Amino Acid Reagent
Amino acids used in this study included p-benzoyl-L-phenylalanine, p-azido-Lphenylalanine, and boc-lysine (Bachem). The amino acids, p-benzoyl-L-phenylalanine (BpF) and
boc-lysine were stored at room temperature, while p-azido-L-phenylalanine (AzF) was stored at 20 oC.
Amino acid solutions were prepared in 0.6 mL, or 1.5 mL at a concentration of 14-60
mM in 30% 1 M NaOH in nanowater {e.g. 2 mg BpF, 150 µL 1 M NaOH, 350 µL nanowater for
a small scale culture of 1-5 mL}.
4.5 Preparation of Cultures – Growth and Lysis
4.5.1 Culture Growth
Inoculants were prepared from plated cells at 30 oC or 4 oC, or from glycerol stocks (6 µL
from -80 oC storage) into KB-T broth with appropriate working concentration of antibiotics (e.g.
3 mL KB-T broth, 3 µL Gen10 stock, 2.6 µL Tet12.5 stock) and grown at 30 oC, 250 rpm for 16-48
hours, until saturation (OD600 > 1.2). Subcultures were then prepared in KB-T broth with
antibiotics as OD600 of 0.4 and grown at 30 oC, 250 rpm to final OD 0.7-1.0. These mid-log OD
(optical density) cultures were charged with working concentrations of 0.5 mM IPTG (Fisher
Scientific).
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Where applicable, induction also required 1 mM BpF or AzF solution or 5 mM Boclysine solution, followed by addition of 1 M HCl at 1:1 molar volume with NaOH in amino acid
solution (e.g. for 150 µL NaOH in 500 uL total amino acid solution, addition of total volume to
culture requires follow-up with 150 µL 1 M HCl. Cultures were incubated until time-point
collection and set into 4 oC refrigerator overnight for 16-20 hours before pelleting cells. Wildtype DC3000 was grown from 4 oC plates in KB-T with no antibiotics, followed by subculture to
OD600 0.4 at the same time as transformed strains, and incubated for equal durations, including 4
o

C overnight refrigeration and further sample preparation.

4.5.2 Cell Lysis Methods
Lysis of cells for protein analysis required re-suspension of collected cell pellets (4 oC,
5000 x g, 10 min; Allegra X6-R) into 2 mL lysis buffer per 50 mL cell culture to allow for
sonication of cells. Sonication lysis buffer contained 20 mM Tris-HCl (Trizma; Sigma Aldrich),
0.5 M NaCl, 10% glycerol and 10 mM imidazole, pH 8.0, unless otherwise noted. Sonication
was effected and total protein content was checked at 280 nm with Nanodrop 2000 to note protein
concentration after complete bursting of cells.
4.6 Purification of Proteins Featuring C-terminal His-tag
All GFPuv-6xHis-tagged proteins expressed as full-length molecular species were
purified using GE Ni2+-Sepharose resin (GE Healthcare) housed in Econo-Pac Chromatography
Columns (BioRad). Purification buffers were as for lysis buffer (3.5.2) except with wash #1 -5
containing 25 mM, 50 mM, 75 mM, 100 mM, and 500 mM imidazole, resp. Each washing step
involved five column volumes of washing buffer, as per manufacturer’s protocol. Protein content
in purification wash fractions was tested by Nanodrop 2000 with respective washing buffers (or
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lysis buffer for total protein, soluble protein, and flow-through) as blank for mg/mL
determination. Where applicable, fractions containing protein of interest were combined and
concentrated using either Amicon Ultra-4 Centrifugal Filter Unit or Amicon Ultra 0.5 mL
Centrifugal Filter, each with 3000 kilodalton (kD) molecular weight cut-off. All Amicon filters
were used according to manufacturer’s protocol and centrifugations were performed at 4 oC in
Sorvall Legend Micro 21R refrigerated microcentrifuge, for 0.5 mL Filter units, or using Allegra
X6-R bench-top centrifuge. For GFPuv proteins purified from DC3000 cultures, no storage
buffer was prepared or used, as protein samples were not needed further for activity assays.
4.7 DNA and Protein Analysis (SDS-PAGE) Methods:
4.7.1 Preparation of DNA Electrophoresis Gels
All DNA electrophoresis gels were made in house as 0.8-1.2% agarose (LE, analytical
grade; Promega) in TAE buffer {200 mM Tris, 100 mM acetic acid, 5 mM EDTA, in nanowater}
featuring ethidium bromide (Promega) as nuclei acid stain at 0.006-0.008% v/v. DNA gels were
solidified on Mini-Gel Caster and DNA gels were run in Mini Sub-Cell GT Cell or Wide MiniSub Cell GT Cell powered by PowerPac Basic Power Supply (BioRad).
4.7.2 Preparation of SDS-PAGE Gels
Denaturing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was
performed using Mini-PROTEAN Tetra Cell electrophoresis chamber and a PowerPac Basic
Power Supply (BioRad). SDS-PAGE gels were made in house as 15% polyacrylamide resolving
gel {25% nanowater, 25% Tris, pH 8.8} with a 10% polyacrylamide stacking gel {55%
nanowater, 25% Tris, pH 6.8}. Electrophoresis was performed in presence of Tris/glycine/SDS
buffer {124 mM Tris, 960 mM glycine, 17 mM SDS, in nanowater}. All SDS-PAGE protein

68

samples were loaded to prepared gels after mixing with 1:1 volume with 2x Laemli Buffer
(BioRad) featuring 5% 2-mercaptoethanol (Sigma Aldrich) and boiled for 15 minutes at 91-98 oC.
Unstained and pre-stained protein marker ladders (BioRad) were used and SDS-PAGE gels were
typically run at either a constant 35 mA or constant 200 volts at room temperature. After running
SDS-PAGE gels were removed from cassette and rinsed in warmed water on rocker to remove
protein sample dye, followed either by staining with Coomassie blue stain {70 mg Brilliant Blue
G-250 (MW 854.02; Fisher Scientific) into 1.0 L nanowater with 3 mL conc. HCl; stir at room
temperature for 4-6 hours} or directly used for Western blot.
4.8 Western Blot Protein Detection
SDS-PAGE gels rinsed in warmed water were soaked in cold (4 oC) Western blot transfer
buffer {25 mM Tris, 192 mM glycine, 20% v/v methanol, pH 8.3-8.5} and set into transfer
cassette against nitrocellulose membrane (BioRad). Membrane transfer was performed at
constant 100 volts for 1 hour in BioRad Mini Trans-Blot Cell transfer chamber at room
temperature (RT) in cold transfer buffer. Transferred membrane were cut for sizing with ethanolrinsed razor and rinsed twice in 10-15 mL PBS (BioRad; 0.5-1.0 NaCl, 0.1-0.25% sodium
dihydrogen phosphate) with added 0.1% Tween-20 buffer (Sigma Aldrich) with rocking for five
minutes at RT. Membrane was then blocked overnight for 16-20 hours at 4 oC, with rocking, in
3% blocking solution (BioRad) and then rinsed twice for 5 minutes in 10 mL PBST buffer.
Primary antibody, 2 µL mouse αHis-tag (Pierce prod #MA1-21315; Thermo Scientific) was
added to PBS + 1% BSA (OmniPure, Calbiochem) for 1:3000 working dilution and membrane
was incubated with rocking for 1-2 hours at RT, followed by five separate washes in 10 mL
PBST for five minutes, each. Secondary antibody, GαM-HRP (BioRad), was diluted to 1:3000 in
PBS + 1% BSA {2 µL into 6 mL solvent} to the membrane and incubated for 1-1.5 hours on
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room temperature rocker. Membrane was then again rinsed five times for five minutes in 10 mL
PBST, each. Colorimetric detection of 6xHis-tagged protein samples on membrane was
performed using Opti-4CN detection (BioRad) according to manufacturer’s protocol, which
involved rocking at RT, covered from light, for 28-30 minutes. All developed membranes were
then rinsed twice for 5-10 minutes in nanowater before imaging on GelDoc XR+.
4.9 Vector Construction and Plasmid-related Culture Preparations
Initial GFPuv (WT and N149TAG), GFPuv/Pyl-tRNA and PylRS vector design was developed
by Wei Niu (University of Nebraska-Lincoln). Plasmids were constructed by the author of this
work. Setup and program methods for all PCR reactions are provided in Appendix I. All
restriction enzymes were purchased from New England Biolabs, unless otherwise noted. All
plasmid maps were designed by the author with SnapGene software {http://www.snapgene.com},
excluding those from cited reference.
4.9.1 pBBR1MCS3-GPFuv N149TAG and pBBR1MCS3-GFPuv WT
Vector pBBR1MCS3 was used for construction of pBBRMCS3-GPFuv N149TAG and
pBBRMCS3-GFPuv WT. Parent vector, pBBR1MCS3, was cut with XbaI and dephosphorylated
for 1 hour with Antarctic Phosphatase (New England Biolabs) at 37 oC, followed by heat
inactivation of enzyme for 5 minutes at 80 oC. Both GFPuv N149TAG and GFPuv WT (wildtype) were cut from their respective pLei-GFPuv vector (group lab stocks) using NheI and XbaI
to feature a 1.1 kb band, and digestions were followed by 1-hour dephosphorylation as for parent
vector. All plasmid digestions were performed at 37 oC for 3 hours and restricted plasmids were
purified via gel electrophoresis with recovery via ZymoClean Gel DNA Recover Kit (Zymo
Research), or directly (pBBR1MCS3) by same Zymo Research column purification kit. Ligation
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of restricted vector and insert was performed at room temperature for 1 hour with T4 Hot Start
ligase (Thermo Scientific) and samples were then set on ice prior to transformation of E. coli
chemical competent cell via heat shock method, or transformation of DC3000 via electroporation.
All pBBR1MCS3 constructs evoke tetracycline resistance to viable transformants.

Figure 29: Plasmid map for pBBR1MCS3-GFPuv (WT or N149TAG)
4.9.2 pBBR1MCS3-GFPuv N149TAG-Mb. Pyl-tRNA (pSR6.067)
Design of vector containing the exogenous tRNA utilized a constitutive promoter based
on the native TRNA-met-3 promoter region in DC3000. The upstream region was amplified via
polymerase chain reaction (PCR) from chromosomal DNA using Pure-link Genomic DNA Kit
(Invitrogen) with primers, tRNA-pBBR-F1-KpnI (5’-GTG GTA CCG ACC TGA TGG GAT TTT
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GCA ATC AAT G-3’ ) and tRNA-pBBR-R1 (5’-TCT GTG TGT CGG CAT TCT ACA GAG-3’),
resulting in a 253 bp product which was used after purification (Zymo Research) for overlapping
PCR with the M. barkeri pyrrolysyl-tRNA sequence (150 bp) amplified from plasmid, pLei-PylT
(group stock). The Pyl-tRNA primers were, tRNA-pBBR-F2 (5’-GAA TGC CGA CAC ACA GAG
GAA ACC TGA TCA TGT AGA TC-3’) and, New-tRNA-pBBR-R2 (5’-GAG ACT GCA GCC TTT
TTT GAT GTT TGG CGG AAA CCC CGG GAA TCT A-3’). The underlined regions in primers,
tRNA-pBBR-F1-KpnI and New-tRNA-pBBR-R2, show the enzyme cutting sites, KpnI and PstI,
respectively. Initial overlapping PCR design featured the terminator region of TRNA-met-3,
rather than a generic poly-A tail, but failure in the annealing stage inspired use of fewer primers
pairs. All PCR reaction involved KOD Polymerase (EMD Millipore). Overlapping PCR was
performed with 15 ng/uL DNA templates and primers, tRNA-pBBR-F1-KpnI and New-tRNApBBR-R2 at 69.5 oC annealing temperature to yield product which was digested with KpnI and
PstI and purified by DNA gel electrophoresis and column purified.

72

Figure 30: Illustration of overlapping PCR showing regions (R1 and F2) overlapped and primers
(F1 and R2) used during final PCR program. Restriction sites, KpnI and PstI are shown in
original fragments and final combined PCR product.
Next, vector pBBR1MCS3:GFPuv N149TAG (KpnI, PstI) was ligated with prepared PyltRNA fragment (KpnI, PstI) to obtain purified plasmid with proper insert. This new construct,
pSR6.067, contains the GFPuv N149TAG mutant reporter protein, as well as the exogenous PyltRNA flanked by the native DC3000 tRNA-met-3 promoter (upstream) and a general terminator
region. This construct ensures recognition of the exogenous Pyl-tRNA by the DC3000
transcription machinery and promotion of the reporter protein under T5-based IPTG induction.
To test for successful ligation, three colonies were picked for separate inoculations of LB
broth with added tetracycline, grown 19 hours at 37 oC, 250 rpm, and after cell collection and
miniprep, plasmids were digested with HindIII for 1 hour at 37 oC before analysis on 1.0% DNA
agarose gel.
Plasmid pSR6.067 was transformed into wild-type DC3000 and plated cells were used to
inoculate KB-T (Tet10) media and grown at 30 oC, 250 rpm before subculture and growth to midlog OD600. Induced cultures (IPTG) were examined for cell-based fluorescence.
A repeat trial of DC3000:pSR6.067 fluorescence in cells was performed for a 5-day
period to ensure no Pyl-tRNA interaction with DC3000 translation machinery. For this
experiment, glycerol stock was used to inoculate KB-T broth with added tetracycline and samples
were shaken at 30 oC to saturation, and a 4 mL subculture prepared at OD600 0.4, and induced at
mid-log OD600. Time-points of 48, 72, 96, and 120-hours post-induction were collected as per
2.9.11 and analyzed as described.
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Figure 31: Plasmid map for pSR6.067 (M. barkeri Pyl-tRNA; KpnI, PstI; GFPuv N149TAG).
4.9.3 pML123-tac.PylRS WT
The M. mazei pyrrolysine synthetase (PylRS) was PCR amplified using primers, 5’GAG
AAT TCA TGG ATA AAA AAC CAT TAG ATG-3’ and 5’- GCT CTA GAG CGA AGC GGA
ATT AA TTC GCG AAG-3’, featuring EcoRI and XbaI cutting sites (underlined), respectively,
from vector pBK-PylRS (Hao, 2011) and purified (Zymo Research) before digestion by EcoRI
and XbaI. Similarly, modified vector pJF118EH-mod1 (Furste, 1986; modification by Wei Niu,
University of Nebraska-Lincoln) was digested with EcoRI and XbaI purified by DNA gel
electrophoresis and column purification with ZymoClean Gel DNA Recover Kit (Zymo
Research). Ligation of restricted vector and PylRS insert was performed for 2 hours at room
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temperature with Hot Start T4 Ligase and ligation product transformed into strain, NEB5α,
followed by plating to LB/ampicillin agar plate.
Plasmid, pJF118EH-PylRS, contains a promoter cassette featuring tac.RBS.PylRS which
was amplified using primers, PylRS118toML-B (5’-GAG GAT CCT TAT CCG GTG CAC CAA
TG-3’) and PylRS118toML-H (5’-CGT TCT GAT TTA ACT GTA TCA GGC TG-3’), and PCR
product (1.797 kb) was purified and digested with restriction enzymes, BamHI and HindIII,
isolated by DNA gel electrophoresis and purified by column purification. In addition, plasmid
pML123 was digested with BamHI and HindIII and isolated via DNA gel electrophoresis and
column purification. Cut vector, pML123, and the PylRS insert were ligated for 4 hours at room
temperature, followed by transformation into NEB5α and plating to LB/gentamycin agar plate.

Figure 32: Plasmid map for pML123.tac.PylRS (WT, Y348F, PylRSNAA) into BamHI, HindIII.
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4.9.4 pML123-tac.PylRS Y348F
As for the tac-PylRS (2.9.3), the synthetase cassette was PCR amplified from pBK vector
using primers, 5’GAG AAT TCA TGG ATA AAA AAC CAT TAG ATG-3’ and 5’- GCT CTA
GAG CGA AGC GGA ATT AA TTC GCG AAG-3’, featuring EcoRI and XbaI cutting sites
(underlined), respectively, from vector pBK-PylRS Y348F (group stock) and digested with EcoRI
and XbaI for ligation into vector pJF118EH-mod1. Subsequent steps for inserting tac.PylRS
Y348F cassette into pML123 (BamHI/HindIII) were also as for wild-type PylRS (3.9.3).
This plasmid featuring the mutated PylRS was co-transformed into Genehog and DC3000
cells along with vector, pSR6.067, for fluorescence analysis of cells induced with IPTG only (ind
-) or IPTG and 5 mM boc-lysine (ind +) and grown overnight at resp. incubation temperatures,
following overnight incubation without shaking at 4 oC.
For a 48-hour study DC3000 cells containing plasmid pSR6.067 alone, or with
pML123.tac.PylRS (WT or 368F) were cultured and induced (where applicable) with IPTG and
boc-lysine. 1 mL samples were pulled from 30 oC incubated cultures, stored overnight (12 hours)
at 4 oC, and then centrifuged {10 min, 16 000 x g, 4 oC} and stored at -80 oC until time of
fluorescence reading. Reconstituted cells were washed three times in PBS buffer and examined
for RFU, then OD600 values were read and RFU/OD calculated for comparison.
4.9.5 pML123-tac.PylRS-NAA Mutant
From a PylRS Y348F synthetase library stock in our group labeled, BL-5, cells at 107 and
105 dilutions were plated on LB/Tet12.5/Kan50/Cm100 agar plates and mid-sized colonies were used
to inoculate liquid LB media with appropriate antibiotic concentrations. Plasmids were purified
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and transformed into E. coli “pREP-PylT” cells for positive selection by plating on
LB/Tet25/Kan50/Cm50 plates.
From the BL-5 library plating, 2 colonies were selected from 107 dilution plating, used to
inoculate liquid and streaked to produce 100s of CFU and two were picked for inoculation and
plasmid purification. The PylRS Y348F fragment was successfully amplified with PCR primers
used for PylRS WT (4.9.3), the PCR product was digested, and ligated into pJF118EH-mod1 to
produce pJF-PylRS Y348F. From this pJF-PylRS Y348F, the tac.RBS.PylRS Y348F cassette
was amplified as before (4.9.3), restricted (BamHI/HindIII) and inserted into prepared pML123
(BamHI/HindIII). Six colonies of transformants featuring pML123-PylRS Y348F were analyzed
and vector pSR7.040.6 was obtained. This vector, containing evolved PylRS Y348F to recognize
natural amino acid (NAA) was transformed into DC3000:pSR6.067 or co-transformed with
pSR6.067 into Genehog. Inoculations were prepared as before and induced at mid-log OD600
with 0.3 mM IPTG and grown at respective temperatures before overnight incubation at 4 oC and
cell-based fluorescence analysis.
4.9.6 pBBR1MCS3.T5-PylRS WT, pML123.T5-PylRS WT, and pML123.T5-PylRS Y348F
According to Figure 32, shown below, PCR amplification of PylRS (WT or Y368F) from
resp. pBK-PylRS initial PCR amplified products of PylRS or PylRS Y348F were digested with
EcoRI and XbaI as before (4.9.3) and inserted into pET28a (Invitrogen) within EcoRI and XbaI
sites to produce pET28a-PylRS WT and pET28a-PylRS Y348F. Plasmids were purified by
miniprep and digested by NdeI and SacI for ligation into the pLei-GFPuvN149TAG vector (NdeI,
SacI), which had been digested to remove the GFPuv protein, but kept the T5.RBS cassette and
the 6xHis tag. Ligation was successful and transformation into Genehog c.c. cells allowed for
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miniprep and subsequent digestion with NheI and XbaI. Vectors pBBR1MCS3 and pML123
were both digested with XbaI and dephosphorylated with Antarctic phosphatase. Ligation of the
T5.RBS.PylRS (WT or Y348F) cassette into both vectors was performed for 4 hours at room
temperature.
The new synthetase plasmids, pML123.T5.PylRS (WT or Y348F) were transformed into
DC3000 and Genehog cells for cell-based fluorescence readings. A series of experiments were
then conducted to test incorporation in cultures induced with IPTG and boc-lysine at (a) 20- and
42-hours post-induction, (b) 12-hour time-point collection (12-48 hours total), and cultures
induced with IPTG and boc-lysine (ind +) or as IPTG-only (ind -).
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Figure 33: Construction scheme for pBBR1MCS3.T5.PylRS (WT and Y348F) (shown) and
pML123.T5.PylRS (WT and Y348F) (not shown); both feature the same final digestion (XbaI).
4.9.7 Introduction of the M. jannaschii Tyrosyl-tRNA and RS System
The following details the development of a system for incorporation of unnatural amino
acids into the model plant pathogen, P. syringae pv. tomato DC3000.
4.9.7.1 Construction of pBBR-GFPuv N149TAG-M. jannaschii Tyrosyl-tRNA (pSR8.010)
To construct vector pSR8.010, containing the M. jannaschii Tyrosyl-tRNA, it was
required to implement overlapping PCR methods similar to the Pyl-tRNA vector (pSR6.067)
construction shown in 3.9.2. Primers used for amplifying the Tyr-tRNA from its pLei vector
were: MjtRNA-pBBR-F2 (5’-GAA TGC CGA CAC ACA GAC CGG CGG TAG TTC AGC AGG3’) and MjtRNA-pBBR-R2 (5’-GAG ACT GCA GCC TTT TTT GAT GTT TGG TCC GGC GGG
CCG GAT TTG A-3’). Subsequent overlapping with TRNA-met-3 promoter region required 15
ng/uL DNA templates and primers, tRNA-pBBR-F1-KpnI and MjtRNA-pBBR-R2 at 69.5 oC
annealing temperature. The overlapping PCR product was digested with KpnI and PstI, isolated
by DNA gel electrophoresis and column purified before ligation in KpnI, PstI-digested pSR6.067.
The final construct, pSR8.010 features the Tyr-tRNACUA from M. jannaschii (Mj.) as well as the
GFPuv N149TAG reporter protein.
DC3000 wild-type cells were transformed with pSR8.010 for inoculation in KB-T culture
and incubation with or without addition of 0.5 mM IPTG for cell-based fluorescence test in
comparison to DC:6.067 induction with or without addition of 0.5 mM IPTG.
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In addition, a single fluorescence test of 120-hour P.I. DC3000 cultures expressing
pSR8.010 was performed. Mid-log cultures were induced with 0.5 mM IPTG (ind-), and incubate
at 30 oC, 250 rpm for 120 hours, followed by 18 hours at 4 oC. 1 mL of collected cells were
washed 3x in PBS (500 µL) before analysis. OD600 values were obtained at 10x dilution of
culture sample and back-calculated for RFU/OD results.

Figure 34: Plasmid map for pSR8.010 (M. jannaschii Tyr-tRNA,KpnI, PstI; GFPuv N149TAG)
4.9.7.2 pML123.T5-BpFRS (pSR8.017)
Mj. Tyr RS evolved to specifically recognize the unnatural amino acid, p-benzoyl-Lphenylalanine (BpF) was amplified out of plasmid pBK-BpFRS using PCR primers, R1-YRSpML123-T5 and TyRS-lib1-F1-NdeI (Nanxi Wang, University of Nebraska-Lincoln). The
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sequence for primer, R1-YRS-pML123-T5 (5’-TAT TGA GCT CCT GCA GTT ATA ATC TCT
TTC-3’), features a SacI cutting site (underlined), while primer, TyRS-lib1-F1-NdeI (5’-TTG
AGG AAT CCC ATA TGG ACG A-3’) contains an NdeI cutting site (underlined). Afterward,
the PCR product was digested with NdeI, SacI, and ligated for 3.75 hours into the intermediate
pLei-GFPuv N149TAG-Mj. Tyr-tRNACUA , which had been previously digested (NdeI, SacI) to
remove the GFPuv protein for constructing the T5.RBS. Mj. Tyr-tRNACUA cassette. This cassette
was removed from vector (XbaI, NheI) and inserted into pML123 (XbaI) to produce pSR8.017.
Plasmid pSR8.017 was used to transform DC3000 cells to yield strains DC3000:pSR8.017 and
DC3000:pSR8.010:pSR8.017.
An initial fluorescence test was performed for cells featuring pSR8.010 and pSR8.017.
Plated cells were used to inoculated KB-T broth with gentamycin and tetracycline and grown
overnight to saturation. Subcultures were prepared and induced at mid-log OD600, induced, and
were incubated for 36 hours at 30 oC, 250 rpm, then set for 24 hours at 4 oC before collecting 1
mL of each culture {4 oC, 16 000 x g, 8 min} and storage at -80 oC until fluorescence assay
preparation. Thawed cultures were resuspended in equal volume of PBS and OD600 values were
taken at 10x dilution and then back-calculated for RFU/OD values after.
In addition, replicates were performed to average of fluorescence data for three trials for
DC3000:pSR8.010:pSR8.017. All cells were prepared as before and incubated post-induction for
44-48 hours followed by 20 hours at 4 oC without shaking. Cell pellets were prepared as
described for fluorescence analysis with examined samples either normalized to OD600 0.1 or
directly at OD600 0.8 to 1.2.
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Figure 35: Plasmid map for pSR8.017 (pML123.T5.BpFRS; XbaI); pSR8.044 is similar.
4.9.8 pML123.T5-TyrRS WT (pSR8.037)
To help understand reasons for apparent low incorporation of BpF into GFPuv N149TAG
present in DC3000, the wild-type tyrosyl-tRNA synthetase (TyrRS WT, or TyrRS) was inserted
into the pML123 synthetase vector under promotion of T5 with the corresponding RBS found in
previous T5 cassettes from pLei vectors: From vector pBK-MjTyrRS (Chin, 2002), the TyrRS
was PCR amplified using the same primers as for the BpFRS from its corresponding pBK vector,
followed by digestion with NdeI and SacI. Digested TyrRS fragment was inserted into pLei
vector to replace GFPuv protein DNA sequence (NdeI, SacI) and vector pLei-TyrRS WT was
then restricted by BamHI and XhoI to produce insert fragment for ligation into pML123 (BamHI,
XhoI). It was necessary to use lab-produced strain, Genehog F`, featuring an F` fertility plasmid
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with gentamycin resistance. Therefore, plasmid miniprep required inoculation into LB media
with kanamycin instead of gentamycin – possible because pML123 contains both gentamycin and
kanamycin resistance markers. The final product, vector pSR8.037 featured the wild-type TyrRS
that is counterpart to the M. jannaschii Tyr-tRNA present in vector pSR8.010.
Cultures were inoculated, grown to saturation OD600, and sub-cultured for induction with
and without IPTG (0.5 mM working concentration) for growth at 30 oC, 250 rpm. Cultures for
fluorescence assays were collected at determined time-points and stored overnight at 4 oC before
fluorescence analysis of cell pellets or liquid culture suspensions. An initial 36-hour trial was
performed, followed by a series of 44-48 hours induction experiments.

Figure 36: Plasmid map for pSR8.037 (pML123.T5.TyrRS WT; BamHI, XhoI)
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4.9.9 pML123.T5-AzFRS (pSR8.044)
Synthetase vector, pSR8.044, was constructed as follows: AzFRS sequence was PCR
amplified from pBK-AzFRS using the same primers used for BpFRS and TyrRS (4.9.7, 4.9.8).
As before, PCR product was digested with NdeI and SacI. Digested AzFRS fragment was
inserted into pLei vector to replace GFPuv protein DNA sequence (NdeI, SacI) and vector pLeiAzF was then restricted with NheI and XbaI and ligated into pML123 (XbaI). The final construct,
pSR8.044 is able to selectively recognize p-azido-L-phenylalanine for charging onto the cognate
tyrosyl-tRNACUA found in pSR8.010.
DC3000 transformants harboring plasmids pSR8.010 and pSR8.044 were prepared and
tested for fluorescence of cells after 36 hours of incubation in presence on IPTG with and without
addition of 1 mM AzF and with or without covering culture flasks in aluminum foil.
To compliment studies in DC3000, pSR8.010 and corresponding synthetase vectors were
transformed into Genehog (BpFRS, AzFRS) or NEB5α F’ competent cells (TyrRS WT). Single
colonies were used to inoculate LB broth with appropriate antibiotics and after subculture of
saturated inoculants, strains in liquid media were induced with 0.5 mM IPTG working
concentration and, where applicable, 1 mM BpF or AzF. No added tyrosine was given to NEB5α
F’:pSR8.010:pSR8.037 (TyrRS) cells. Cultures were grown overnight at 37 oC, 250 rpm, then set
at 4 oC or 16-20 hours before pelleting, washing in PBS, and fluorescence analysis after dilution
to OD 0.1.
4.9.10 New Mj. Tyrosyl-tRNA Promoters: lpp and proK
To attempt an increase in the Tyr-tRNA transcription, two additional promoters were
substituted in place of the original tRNA-met-3 sequence from DC3000.
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From vector pLei-GFPuv N149TAG-Mj Tyr-tRNA the lpp.MjtRNA.terminator cassette
featuring the lpp promoter and terminator regions flanking the Tyr-tRNA was amplified by PCR
using primers, lpp-tRNA-F-KpnI (5’-GAG AGA GGG TAC CCG GGA TGT GCT GCA AGG CGA
TTA AG-3’) and lpp-tRNA-R-XmaI (5’-ATA TAT CCC GGG CCC TGG CGC CGC TTC TTT
GAG-3’) which contain KpnI and XmaI restriction sites, resp. Digestion of fragment at noted
cutting sites allowed for ligation into pBBR1MCS3-GFPuv N149TAG (KpnI, XmaI) to produce
pSR8.052.1. This plasmid was transformed into DC3000 WT and DC:pSR8.017 (pML123BpFRS) and this strain was further analyzed for cell-based and culture supernatant fluorescence.
Vector pSR8.052.2, implementing the proK promoter and terminator (term.) regions, was
prepared similarly as for the lpp promoting cassette. proK.MjtRNA.term was PCR amplified
from pEvol vector (Young, 2010) using primers, proK-tRNA-F-KpnI (5’-GAG AGA GGG TAC
CGA GCA CCG GTT TAT TGA CTA CC-3’) and proK-tRNA-R-XmaI (5’-ATA TAT CCC GGG
TTT TTT AAG GCA GTT ATT GGT-3’) which feature restriction sites for KpnI and XmaI,
respectively. PCR product was digested with restriction enzymes for the noted cutting sites,
isolated by DNA gel electrophoresis and column purification, and ligated into plasmid
pBBR1MCS3-GFPuv N149TAG (KpnI, XmaI) to produce pSR8.052.1. This plasmid was
transformed into DC3000 WT and DC:pSR8.017 (pML123-BpFRS) and this strain was further
analyzed for cell-based and culture supernatant fluorescence.
DC3000 cells featuring pSR8.017 (BpFRS) were transformed with tRNA plasmids
featuring either the lpp, or proK promoters and plated cells were used for inoculation of KB-T
broth with added antibiotics. Cells were grown alongside DC3000:pSR8.010:pSR8.017 for one
or two days to saturation, subculture was prepared and then induced at mid-log OD. Induced
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cultures were grown for several days with time-points collected at 48, 72 hours. Cell pellets and
liquid culture supernatant were analyzed for fluorescence.
Three additional series of DC3000 cultures harboring pSR8.052.1 (lpp) and pSR8.017
plasmids were prepared as above and examined for fluorescence of cell pellets over several days.

Figure 37: Plasmid map for pSR8.052.1 (lpp promoter/Mj. Tyr-tRNA; KpnI, XmaI)
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Figure 38: Plasmid map for pSR8.052.2 (proK promoter/Mj. Tyr-tRNA; KpnI, XmaI)
4.10 GFPuv Purification from DC3000 Liquid Broth
Inoculants were prepared from plated cells at 30 oC or 4 oC, or from glycerol stocks (6 µL
from -80 oC storage) into KB-T broth with appropriate working concentration of antibiotics (e.g.
3 mL KB-T broth, 3 µL Gen10 stock, 2.6 µL Tet12.5 stock) and grown at 30 oC, 250 rpm for 16-48
hours, until saturation (OD600 > 1.2). Subcultures were then prepared in KB-T broth with
antibiotics as OD600 of 0.4 and grown at 30 oC, 250 rpm to final OD 0.7-1.0. Induction of mid-log
OD cultures featured working concentrations of 0.5 mM IPTG and 1 mM BpF or AzF solution or
5 mM Boc-lysine solution. Cultures were incubated until time-points of 48, 72, 96, and 120hours post-induction (P.I.) from which 250-300 µL volumes were taken from incubated culture
stock and set into 4 oC refrigerator overnight (16-20 hours). Wild-type DC3000 was grown from
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4 oC plates in KB-T with no antibiotics, followed by subculture to OD600 0.4 at the same time as
transformed strains and incubated for equal durations, including 4 oC overnight refrigeration and
further sample preparation.
Cell pellets for all time-points were collected from liquid cultures at 4 oC, 21 100 x g, 15
minutes and supernatants were transferred to 0.6 mL tubes for storage on ice. Pellets were
washed in equal volume of PBS solution {10 mM Na2HPO4, 140 mM NaCl, pH 7.0} with
vortexing, followed by centrifugation at 4 oC, 14 000 x g, 10 minutes for a total of three washes.
All collected cell pellets or liquid media for each time-point was stored at -80 oC or 4 oC,
respectively, to allow for multiple sample fluorescence analysis on the same day. Liquid media
for time-points was kept at -20 oC or -80 oC after fluorescence analysis for later use in Western
blot detection.
Samples were loaded to 15% prepared SDS-PAGE gel after boiling at 94 oC for 15.5
minutes in presence of equal volume 2x Laemli buffer. Loaded samples were run in Tris/Glycine
buffer at either constant current of 35 mA to 38 mA or constant voltage of 200 V. After
electrophoresis, gel was washed in warmed nanowater at room temperature until blue dye on gel
had dissipated and then either stained in Coomassie blue staining solution or used directly for
Western blot transfer.
4.11 GFPuv WT Western Blot
Liquid media samples from DC3000 expressing GFPuv WT at 72, 96, and 120 hours
post-induction (P.I.) were measured for protein concentration (mg/mL) at 280 nm with Nanodrop
2000. Higher concentrated samples were normalized to 25 µg for loading to 15% SDS-PAGE gel
and further His-tag detection using Western blot colorimetric method. These time-points were
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loaded alongside normalized sample of DC3000 WT secretion (liquid media) at 120 hours P.I.
Additionally, 20 µL volumes of concentrated fraction from DC3000 featuring M. barkeri PyltRNA and GFPuv N149TAG mutant (pSR6.067 non-induced and IPTG induced) were loaded to
SDS-PAGE gel for comparison under Western blot detection
4.12 Western Blot for 6.067
To determine if DC3000:pSR6.067 cultures contained secreted GFPuvN149-XX,
combined purification fractions at wash #2 (50 mM imidazole) and wash #3, 4 (75 mM, 100 mM
imidazole) were analyzed against DC3000:GFPuv WT supernatants (4.9.12) and DC WT 120hours supernatant samples. 280 nm absorbance readings of these fractions did not show
appreciable protein concentration, so 20 µL of each was mixed with equal volume of Laemli
loading buffer for sample preparation and loading to SDS-PAGE gel.
4.13 Purification of GFPuv N149-BpF from Medium-scale Culture for DC:6.067
To ensure there is no GFPuv N149TAG-XX mutant being expressed and secreted to the
culture supernatant, a 25 mL scale culture was prepared and purification of possible full-length
GFPuv N149-XX mutant was attempted.
A 2.5 mL volume of KB-T broth was inoculated with plated cells and grown to saturation
in presence of tetracycline and gentamycin. A 1.0 mL portion of the inoculant was added to 25
mL KB-T (with 25 µL Gen10 stock, 20 µL Tet12.5 stock) and grown at 30 oC, 250 rpm to OD600 of
0.8. Culture was then separated as 2 mL for non-induced and 24 mL for induction with IPTG at
0.5 mM working concentration. Cultures were grown at 30 oC, 250 rpm for 96 hours before
setting overnight (20 hours) at 4 oC. 250 µL of each raw suspension was then prepared for
supernatant and cell-based fluorescence analysis, while the remaining portions were centrifuged
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for supernatant extraction, and supernatants were frozen at -20 oC until purification. For original
250 µL aliquots, 30 mg of each induced and non-induced were lyzed in Tris/glycerol lysis buffer
(pH 8.0) and protein concentration detection with Nanodrop 2000 at 280 nm. 50 µg each total
protein portion was then prepared for SDS-PAGE and western blot analysis alongside GFPuv WT
supernatant samples from DC3000 (4.9.12).
The supernatant fraction (~ 24 mL) of the induced DC3000:pSR6.067 culture was thawed
overnight at 4 oC and loaded to column with 1 mL Ni2+-Sepharose resin. Flow-through (FT) was
reloaded twice before washing with 25 mM imidazole in wash #1, followed by wash buffer series
#2-5 (50-500 mM imidazole). Washes #2-5 were combined and concentrated by Amicon Ultra-4
Centrifuge Device to 300 µL prior to storage at 4 oC.
4.14 Western Blot for 96-hour Culture Liquids Media
96-hour culture supernatants were analyzed by Western blot protocol to determine if any
full-length GFPuv N149 mutant was had been secreted by DC3000. Supernatant samples were
examined for protein concentration (mg/mL) with Nanodrop 2000 and normalized to 25 µg total
protein before SDS-PAGE sample preparations (Laemli dye, boiling) and loading to gel alongside
GFPuv WT loading control. Electrophoresis gel was then transferred to nitrocellulose membrane
and membrane was incubated and developed as previously described, but featuring 1.5 hours
incubation for both primary and secondary antibodies. Membrane was developed and image was
captured.
The 96-hour samples analyzed during this trial included DC3000 WT 96-hrs, GFPuv
N149TAG only (non, induced IPTG), pSR8.010 only (non, induced IPTG), pSR8.052.2 (proK)
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only (non, induced IPTG), pSR8.010:pSR8.037 (non, induced IPTG), and pSR8.010:pSR8.044
(AzFRS; non, induced IPTG, induced IPTG with 1 mM AzF).
4.15 Western Blot for DC:pSR8.010: pSR8.017 (BpF) and DC:pSR8.052.1 (lpp): pSR8.017
To ensure no full-length GFPuv-N149BpF mutants were being secreted into the liquid
media, 96-hour and 120-hour supernatant samples were prepared for SDS-PAGE and Western
blot detection with 6x-His antibody. Nanodrop 2000 was used to obtain protein concentrations
(mg/mL) at 280 nm and samples for loading were prepared at 25 µg total protein based on those
280 nm readings. Samples were loaded to 15% SDS-PAGE gel and later transferred to
nitrocellulose membrane. Overnight blocking in 3% blocking buffer was performed at 4 oC, with
rocking, and subsequent incubation of the membrane at RT in presence of primary (1.5 hours)
and secondary (1.5 hours) antibodies, with a final colorimetric development were all performed.
Membrane blot was imaged.
4.16 Purification of GFPuv N149-BpF from Medium-scale Culture for
DC:pSR8.010:pSR8.017 and DC:pSR8.052.1 (lpp):pSR8.017
Medium-scale (28 mL) cultures of DC3000 featuring either pSR8.010 + pSR8.017
(BpFRS) or pSR8.052.1 (lpp) + pSR8.017 were prepared as follows: 2.5 mL KB-T was
inoculated from glycerol stock (pSR8.010 + pSR8.017) or agar plate stored at 4 oC for 2 months
(pSR8.052.1 + pSR8.017) and incubated with antibiotics at 30 oC, 250 rpm overnight. Cultures
were then directly added to 25 mL KB-T in 125 mL Erlenmeyer flask with added antibiotics and
grown to OD600 of 1.0. At this time, 2 mL of each was transferred to culture tube to serve as
possible non-induced control, while the remaining fractions were induced with 500 µL of 55.7
mM BpF solution {15 mg BpF, 300 µL 1 M NaOH, 700 µL ddH2O}, 150 µL 1 M HCl (to
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neutralize NaOH}, and 140 µL 100 mM IPTG (0.5 mM working concentration). All cultures
were then incubated for 50 hours at 30 oC, 250 rpm. 500 uL of initial induced suspensions were
transferred to 1.5 mL centrifuge tubes for supernatant and cell pellet fluorescence analysis. The
remaining cultures were collected {4 oC, 5000 x g, 50 minutes} and stored at -80 oC until lysis
and purification. Lysis was performed in 3 mL (pSR8.010 + BpFRS) or 6 mL (pSR8.052.1 +
BpFRS) of lysis buffer {50 mM Tris, 100 mM NaCl, 1 mM EDTA, pH 8.0} with sonication on
ice until lysate samples were clear {5 minute rounds on ice as: 10 sec. pulse, 30 sec. pause, 6065% power; 5 rounds (pSR8.010 + BpFRS) or 7 rounds (pSR8.052.1 + BpFRS) total} and lysates
were frozen immediately at -80 oC until centrifugation and lysis supernatant collection {4 oC, 21
100 x g, 30 min}. Select purification fractions of DC:pSR8.010:pSR8.017 were analyzed by
SDS-PAGE, while fractions (Wash #1-1, 2-1, 3-1, 4-1) for both induced strains were analyzed by
Western blot. Relevant purification fractions from both were analyzed for protein concentration
at 280 nm with Nanodrop 2000 with appropriate lysis and wash buffers as blanks. Where
applicable, protein samples were normalized to 25 µg for gel loading.
4.17 Fluorescence Assays
All fluorescence assays were performed using the SynergyH1 microplate reader (BioTek)
with Costar 96-well black flat-bottom fluorescence plates (#3915; Corning). All readings were
performed at 19-25 oC ambient temperature with 100x gain, 7.0 mm read height, and excitation at
390 nm with emission at 510 nm. Sample buffer included blanking in phosphate-buffered saline
solution (PBS) {10 mM Na2HPO4, 140 mM NaCl, pH 7.0}.
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4.17.1 Cell Pellets
Pellets of cells were washed three times in equal volume of PBS buffer {4oC, 14 000 x g,
10 minutes each} as preparation for analysis. Cell pellet suspensions were homogenized as best
able and liquid-only portions were assayed. Fluorescence readings were performed on cell pellets
after testing optical density at 600 nm (OD or OD600) at 10x dilution {i.e. 100 µL per 900 µL
nanowater} or 20x dilution {i.e. 50 µL sample per 950 µL nanowater}, depending on the turbidity
of the culture. Unless otherwise noted, samples were normalized to OD = 0.05 or OD 0.1 before
loading to black flat-bottom microplate at volumes of 125 µL sample per well.
Blanking of analyzed samples was performed with PBS only for cell pellets, unless
otherwise noted.
4.17.2 Cell Culture Liquid Supernatant
Supernatants for cultures were analyzed as 5 µL liquid media in 120 µL PBS buffer. An
additional reading was performed for a solution of either KB-T in PBS or KB-T/Tet10 in PBS.
Over the series of sample readings, values for KB-T/Tet10 (5 µL solution into 120 µL PBS) were
averaged for correction against fluorescence caused by tetracycline in the culture broth.
Blanking of analyzed samples was performed with PBS + KB-T for supernatants.
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APPENDIX I – PCR AMPLIFICATION SETUP AND PROGRAM METHODS

PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPS
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

33.5
5
5
3
1.5
1
1

PCR Method
o

95 C
95 oC
64.6 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

o

5.5 seconds
7.5 minutes

Extension
Termination

70 C
70 oC

* 30 cycles

Table 21: PCR Method for TRNA-met-3 Promoter (DC3000) Amplification
PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

33.5
5
5
3
1.5
1
1

PCR Method
95 oC

2 minutes

Activation

o

20 seconds

Denaturing

o

10 seconds

Annealing

o

5 seconds
7.5 minutes

Extension
Termination

95 C
56 C
70 C
70 oC

Table 22: PCR Method for Pyl-tRNA Amplification

* 30 cycles
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PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer

33.5
5
5

25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

3
1.5
1
1

PCR Method
o

95 C
95 oC
69.5 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

70 oC
70 oC

5 seconds
7.5 minutes

Extension
Termination

* 30 cycles

Table 23: PCR Method for Overlapping PCR of M. barkeri Pyr-tRNA with TRNA-met-3
Promoter Region
PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

33.5
5
5
3
1.5
1
1

PCR Method
95 oC
95 oC
60.5 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

o

30 seconds
7.5 minutes

Extension
Termination

70 C
70 oC

Table 24: PCR Method for PylRS from pBK Amplification

* 30 cycles
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PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

33.5
5
5
3
1.5
1
1

PCR Method
95 oC

2 minutes

Activation

95 C
63.1 oC

20 seconds
10 seconds

Denaturing
Annealing

o

32 seconds
7.5 minutes

Extension
Termination

o

70 C
70 oC

* 30 cycles

Table 25: PCR Method for PylRS from pJF118EH-mod1 Amplification
PCR Setup
Component
Vol. (µL)

PCR Method
o

ddH2O
2 mM dNTPs
KOD 10x Buffer

16.75
2.5
2.5

95 C
95 oC
56 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

1.5
0.75
0.5
0.5

70 oC
70 oC

5 seconds
7.5 minutes

Extension
Termination

* 30 cycles

Table 26: PCR Method for M. jannaschii Tyr-tRNA from pLei-GFPuvN149TAG-Mj. Tyr-tRNA
Amplification
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PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

33.5
5
5
3
1.5
1
1

PCR Method
95 oC
95 oC
69.5 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

o

5 seconds
7.5 minutes

Extension
Termination

70 C
70 oC

* 30 cycles

Table 27: Overlapping PCR of M. jannaschii Tyr-tRNA with TRNA-met-3 Promoter Region
PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

16.75
2.5
2.5
1.5
0.75
0.5
0.5

PCR Method
o

95 C
95 oC
70 oC
o

70 C
70 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

15 seconds
7.5 minutes

Extension
Termination

* 30 cycles

Table 28: PCR Method for Amplification of lpp/Mj. tRNA/term Region from pLei vector

102

PCR Setup
Component
Vol. (µL)
ddH2O
2 mM dNTPs
KOD 10x Buffer
25 mM MgSO4
10 µM Primer Mix
KOD Polymerase
DNA Template

16.75
2.5
2.5
1.5
0.75
0.5
0.5

PCR Method
o

95 C
95 oC
70 oC
o

70 C
70 oC

2 minutes
20 seconds
10 seconds

Activation
Denaturing
Annealing

15 seconds
7.5 minutes

Extension
Termination

* 30 cycles

Table 29: PCR Method for Amplification of proK/Mj. tRNA/term Region from pEvol Vector
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APPENDIX II – DNA AGAROSE GEL IMAGES
DNA agarose gels for plasmid constructs, including PCR amplification, overlapping
PCR, and ligation insert tests.

Figure 39: DNA gel for pLei-GFPuv N149TAG small-scale digestion with NheI and XbaI. In
both pLei-GFPuv N149TAG and pLei-GFPuv WT, proper band at 1.1 kb is cut, purified, and
ligated to pBBR1MCS3 (XbaI). Image shows non-digested (non) and digested (‘/.) products.
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Figure 40: DNA agarose gels showing initial PCR product of Pyl-tRNA (left; PylT) and
properly-sized overlapping PCR product (right) of promoter/tRNA/terminator.

Figure 41: DNA gel for restrictions of vector (pBBR1MCS3-GFPuvN149TAG, left) and PyltRNA fragment (right).
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Figure 42: Ligation check for proper Pyl-tRNA insert in pSR6.067 ligation product. Restriction
of plasmids with HindIII to produce two bands (3.66 kb, 2.94 kb) if proper insert, otherwise three
bands (3.66 kb, 1.64 kb, 0.995 kb) if no tRNA insert. Lanes (left to right): 1, 1 kb ladder; 2, nondigested sample #1; 3, digested sample #1; 4, empty lane; 5, non-digested sample #2; 6, digested
sample #2; 7, non-digested sample #3; 8, digested sample #3.

106

Figure 43: DNA gels showing PCR amplification products for pJF118EH-PylRS WT Construct
(left image). DNA gels (right image) showing digestion products for PylRS PCR fragment
(EcoRI, XbaI), pJF118EH-mod1 (EcoRI, XbaI) and pML123 (BamHI, HindIII)

‘/. pLei-PylRS Y348F

Figure 44: DNA gels showing digestion of pLei-PylRS Y348F (NheI, XbaI) for ligation into
pML123 (NheI, XbaI).

Figure 45: PCR amplification of tac.PylRSNAA cassette from pJF118EH-mod1 vector for
digestion and insertion into pML123 (BamHI, HindIII).
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Figure 46: DNA gels showing digestion of M. jannaschii Tyr-tRNA promoter//tRNA, terminator
overlapping PCR product (KpnI, PstI). Band was excised, purified, and ligated into
pBBR1MCS3-GFPuv N149TAG.

Figure 47: PCR product for amplification of BpFRS from pBK-BpFRS vector.
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Figure 48: DNA gels (left image) showing digestion of pML123 (11.6 kb; BamHI, XhoI) and
digestion of pLei-TyrRS WT (BamHI, XhoI) to obtain T5.RBS.TyrRS WT fragment (2.2 kb).
Also shown (right image) is test for proper insert after ligation of pML123 with T5.RBS.TyrRS
insert (expected product is 2.164 kb for BamHI, XhoI digestion).

Figure 49: DNA gels showing PCR amplification products for lpp (left) and proK (right)
promoter//tRNA/terminator from respective parent plasmid.
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Figure 50: DNA gels showing digestion products of overlapping PCR products (0.3 kb lpp, left;
0.5 kb proK, right) for insertion into pBBR-GFPuvN149TAG vector.

Figure 51: DNA gels showing digestion products for T5.AzFRS insert (left image; 1.3 kb from
pLei) after ligation into pML123 (XbaI). Miniprep from overnight colonies showed 2/8
successful ligation reactions where insert was seen after BamHI, XhoI digestion (right image).
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Figure 52: Digestion of vector pBBR1MCS3-GFPuvN149TAG for insertion of lpp or pro
promoter//tRNA/terminator cassette. Reaction was performed overnight, followed by
dephosphorylation with Antarctic phosphatase.

